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ABSTRACT 
The Effect of Bovine Galectin-1, a Conceptus Secretory Protein, on the Endometrial 
Transcriptome 
Lindsay Faye Grose 
 Early embryonic loss in cattle is detrimental to reproduction thus, the profitability of both 
the beef and dairy industries. Therefore, an important aspect of study is to find techniques that 
beef or dairy producers could use to decrease early embryonic loss Galectin-1, the protein that 
was investigated in this research is important in modulating the maternal immune system in 
rodent and human early pregnancies by promoting fetomaternal immune tolerance. The role of 
galectin-1 within the reproductive tissues has not been thoroughly investigated in cattle. 
Galectin-1 is located in the caruncular and intercaruncular regions of the bovine endometrium, 
specifically the maternal stroma, and in the day 7 blastocyst and the elongating day 16 
conceptus. Expression of galectin-1 was reduced in in vitro produced bovine blastocysts when 
compared to in vivo produced blastocysts, which could cause high embryonic loss and poor 
pregnancy rates for in vitro produced blastocysts. Relative gene expression of galectin-1 was 
reduced in endometrium of low fertility dairy heifers. In this study, the impact of galectin-1 on 
the bovine endometrial transcriptome was evaluated through galectin-1 treatment of intact mid-
luteal phase endometrium and bovine endometrial epithelial and fibroblast cells in a 3-
dimensional culture system. A third experiment compared gene expression of CXCR4, 
EIF4EBP2, IL-1B, IL-6, LIF, CHST15, MST1R, ATP11a, FOXP3, CD11c, IL-2RA, and IL-10 
day 16 pregnant vs. day 17 cyclic bovine endometrium because of their potential importance 
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 Early embryonic loss in cattle affects all aspects of the cattle industry. Research has 
shown that 20-50% of pregnancies may be lost between days 0-7 of gestation. Another 30% may 
be lost between days 8-27 (Wiltbank et al., 2016, Diskin et al., 2006). Overall, reproductive 
failure costs the beef and dairy industries a significant amount of money annually, thus having a 
large impact on U.S. agriculture (Bellows et al., 2002). These findings indicate that the majority 
of pregnancy loss occurs prior to implantation of the conceptus thus, this stage of gestation is an 
important time point for research. A better understanding of pregnancy during this time could 
provide technologies to prevent economic losses for the producer.  
 Galectin-1 (LGALS1) is an important protein during pregnancy for the modulation of 
immune cell function through regulatory T-cells (Treg) in human and rodent endometrium (Blois 
et al., 2007, Camby et al., 2006). In cattle LGALS1 is in the caruncular regions of the 
endometrium and has been found on the conceptus as early as day 16 of gestation (Mamo et al., 
2012, Mohan et al., 2004). Further, LGALS1 expression was reduced in in vitro compared to in 
vivo produced bovine blastocysts and in the endometrium of low fertility dairy heifers (Killeen et 
al., 2014). Possibly, LGALS1 could play a role in the immune modulation in the uterine 









Reproductive failure in cattle results in decreased milk and beef production as well as 
increased treatment and preventative costs, leading to economic losses. Although reproduction 
can be negatively affected by many factors, reproductive failure is a major reason for culling 
animals. The United States Department of Agriculture (USDA) estimated $441-$502 million in 
losses for beef producers and $473-$484 million in losses for dairy producers annually due to 
female reproductive failure. This sums to an aggregate national total of about $1 billion annually 
for the entire cattle industry (Bellows et al., 2002). In beef cattle, although estimates indicate that 
fertilization rate is approximately 90%, the average calving rate to a single insemination is 
approximately 55%, suggesting an embryonic/fetal mortality rate of approximately 45%. Seventy 
to eighty percent of total embryonic loss is believed to occur between days 8 and 16 after 
insemination (Diskin et al., 2006, Spencer and Hansen, 2015b). Early pregnancy loss is even 
greater in the high-producing dairy cow, which is a major limitation to milk production, and 
improvements to reproduction could improve the profitability of dairy farms (Moore and 
Thatcher, 2006, Spencer and Hansen, 2015a, Spencer and Hansen, 2015b).  
During pregnancy, a necessary line of communication is established between the 
developing conceptus and the uterus. Communication prevents luteolysis, structural and 
functional regression of the corpus luteum (CL), and maintains pregnancy. During this time, the 
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conceptus secretes interferon tau (IFNT), the maternal recognition of pregnancy signal in the 
cow, initiating a cascade of events that allows the CL to be maintained with continued 
progesterone (P4) secretion. Possibly, deficiencies in uterine function or failure of the conceptus 
to secrete IFNT during this time and results in failure to undergo implantation and placentation 
(Bazer et al., 2012). 
Nonetheless, pregnancy loss negatively affects economic performance of cattle herds. 
Wiltbank et al. (2016) described four pivotal periods for pregnancy loss during the first trimester 
of gestation in the lactating dairy cow. The first period is the first week of pregnancy with failure 
being attributed to lack of fertilization or loss of the early embryo. The second period is between 
days 8-27 of gestation with inadequate communication from the embryo, uterus and/or ovary, 
causing a loss in pregnancy. The third period is between days 28-60 of gestation. During this 
time the conceptus attaches to the uterus and forms the placenta. The last pivotal period is 
between the days of 60-90 of gestation. This encompasses the time of increased fetal growth and 
increased volume of placental membranes. Approximately 1-3% of pregnancy loss occurs during 
this time possibly because of multiple offspring and overcrowding in the uterus.  
Knowledge of the complex biological and genetic mechanisms governing conceptus 
elongation and implantation and/or factors contributing to the early embryonic loss will lead to 
strategies that improve reproductive success in cattle (Ulbrich et al., 2013, Geary et al., 2016, 
Lonergan et al., 2016, Forde et al., 2015). 
Early Pregnancy 
Following ovulation, the oocyte enters the infundibulum of the oviduct where it will be 
guided through the oviduct by the wave-like motions of the fimbriae. Fertilization occurs in the 
4 
 
ampillary-isthmic junction of the oviduct by a single sperm penetrating the oocyte through a 
series of complex reactions (Langlais and Roberts, 1985). 
 The first reaction is decapitation of the sperm to reveal zona pelucida binding proteins, 
followed by the acrosomal reaction to penetrate the zona pelucida. Vesiculation follows, where 
the two membranes of the oocyte and sperm fuse. After germinal vesicle breakdown, female and 
male pronuclei migrate to the center of the oocyte and the first mitotic division occurs, producing 
a two-celled embryo. The two cells (blastomeres) are smaller than the initial single cell before 
cleavage as a result of cytoplasmic partitioning. The blastomeres will undergo a second division 
within 24 hours following fertilization producing a four-celled embryo. Although blastomeres 
continue to undergo mitosis, the rate of cleavage slows, occurring once every 24 to 26 h. The 
cleavage between blastomeres may not be a synchronized event, as some cells divide faster than 
others. In accordance with the cleavage-driven model, blastomeres that divide more quickly may 
be positioned more toward the exterior of the cell mass, giving rise to the trophoblastic lineage. 
Cells that divide more slowly may be positioned toward the interior, giving rise to the inner cell 
mass (Piotrowska and Zernicka-Goetz, 2001).  
The bovine conceptus enters the uterine horn approximately 4-5 days after ovulation, 
undergoing first morulation followed by blastulation. During morulation, blastomeres located on 
the surface of the morula produce tight cell junctions. The blastomeres pump sodium ions into 
the interior of the morula, resulting in accumulation of fluid and formation of the inner cell mass, 
which ultimately gives rise to the conceptus and fetal body. Hatching occurs near day 10 of 
gestation when thinning of the zona pellucida by the actions of fluid accumulation, growth, 
contraction of the blastocyst, and proteolytic enzymes lead to the expulsion of the blastocyst. 
Once hatched from the zona pellucida, the blastocyst is a free-floating conceptus within the 
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uterine lumen and is dependent on the uterine environment for survival. At this time the 
conceptus undergoes extensive growth. Near day 13, the bovine blastocyst is approximately 3 
mm in diameter. However, by day 17 of gestation, the conceptus is approximately 250 mm in 
length. At this time, the blastocyst will appear as a filamentous thread like structure (Senger, 
2005). After day 19 in cattle, the elongating conceptus will initiate adherence to the uterine 
luminal epithelium (LE) and begin the process of placentation (Spencer et al., 2017, Guillomot et 
al., 1981). 
Maternal Recognition of Pregnancy 
In order for embryogenesis to continue and the pregnancy to be maintained, luteolysis 
must be prevented and high concentrations of P4 must be maintained. In the non-pregnant cow, 
the CL produces oxytocin that stimulates the endometrial cells to synthesize prostaglandin F2-
alpha (PGF2a). The production of PGF2a is dependent upon a threshold number of oxytocin 
receptors that are synthesized by endometrial cells during the estrous cycle. When these 
receptors are available in sufficient numbers, pulsatile secretion of PGF2a occurs in response to 
luteal oxytocin secretion and luteolysis follows. In order to block this luteolytic mechanism, the 
trophoblastic cells of the blastocyst secrete IFNT in the cow and ewe. The IFNT then acts on the 
endometrial cells of the uterus to inhibit the production of oxytocin receptors thus preventing 
oxytocin from stimulating PGF2a. The IFNT also causes secretion of proteins from the uterine 
glands into the uterine lumen to nourish the conceptus. These proteins include alpha- fetoprotein 
(a-FP), bovine placental lactogen (bPL), glycoproteins, and might other uncharacterized proteins 
(Thatcher et al., 1984). The IFNT can exit the uterus through the uterine vein and will reach the 
ovary by counter current exchange with the ovarian artery (Senger, 2005). Progesterone acts on 
the uterus to stimulate and maintain uterine functions that are necessary for early embryonic 
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development, implantation, placentation, and successful fetal and placental development to term. 
The conceptus must signal its presence to the dam through the process of maternal recognition of 
pregnancy. If the conceptus does not do so in a timely manner, luteolysis will occur and the 
pregnancy will be terminated. In cattle, the maternal recognition of pregnancy signal is IFNT, the 
bovine conceptus must secrete IFNT at sufficient concentration between days 15-16 after 
ovulation. This is referred to as the critical period, and at this time the conceptus is in the ovoid 
stage (Degrelle et al., 2005). The bovine blastocyst prevents luteolysis by secreting the 
pregnancy recognition protein, bINF-T. Elongation of the blastocyst is critical for efficient 
production of IFNT and for implantation (Thomas et al., 2004, Farin et al., 1989, Guillomot et 
al., 1990, Gray et al., 2001). It is detectable in the bovine uterus as early as gestational day 7 
(Rashid et al., 2018).   
Attachment/Implantation 
Synchrony between the developing conceptus and uterine environment is critical for 
survival. The endometrium must be receptive to the conceptus, which must attach to the uterine 
surface epithelium between days 18-22 after ovulation (Senger, 2005).  Attachment is enhanced 
within endometrial caruncles, specialized maternal sites of nutrient exchange with the placental 
tissues. There are approximately 100 evenly distributed caruncles within the uterine horns of 
cattle (Schlafer et al., 2000). The trophoblast cells form a continuous epithelial layer of the 
chorion, over the entire surface of the chorioallantois, which is a fusion of the chorionic and 
allantoic tissues. As the fetal placenta forms and develops, villous projections that interdigitate 
with the surface of the caruncle forming a specialized placental tissue referred to as a cotyledon. 
Together, the caruncle and cotyledon tissues form a placentome, a specialized unit for nutrient 
and waste exchange between the mother and the placental tissues. The interdigitation of these 
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two tissues enchances the fetomaternal interface and greatly increases surface contact between 
the cow and fetal calf (Schlafer et al., 2000). 
The bovine endometrium and placenta consist of binucleate trophoblast giant cells (TGC) 
(Wooding and Wathes, 1980). Approximately one-fifth of the bovine trophoblast cells are 
binucleated. These develop from mononuclear trophoblast cells by actokinetic mitosis that 
migrate beyond the maternal luminal epithelial cells or fuse with single maternal epithelial cells 
to form fetomaternal hybrid cells (Schlafer et al., 2000).  
Ultrastructural studies using phosphotungstic acid to stain cytoplasmic granules of 
binucleate cells demonstrated the translocation of binucleate trophoblast cells from the chorionic 
layer of the cotyledonary villi to penetrate the single epithelial cell layer lining the caruncules. 
Similar migration occurs in the interplacentomal areas. As the binucleate cells migrate, they 
routinely fuse with a single endometrial epithelial cell and discharge their cytoplasmic granules. 
The fusion of a fetal binucleate cell with a maternal cell temporarily forms a hybrid cell with 
three nuclei (Schlafer et al., 2000). Since migration does not extend beyond the maternal 
basement membrane, this process is considered as restricted trophoblast invasion. Thus, through 
regulated cell adhesion, migration, and restricted invasion, a complex interface is generated that 
encompasses both fetal and maternal cells. Its functionality is critical for 
trophoblast/endometrium contact and maintenance of pregnancy (Froehlich et al., 2012) 
The binding of integrins to their extra-cellular membrane (ECM) proteins with regulatory 
functions during implantation and trophoblast invasion has been confirmed for the hemochorial 
human placenta (Fisher and Damsky, 1993). Large amounts of ECM proteins, like collagen type 
IV, fibronectin, and laminin were shown during all stages of gestation in the placenta of 
macaques (Blankenship et al., 1992, Blankenship and King, 1993). In contrast, understanding of 
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the cell-cell interactions in other types of placentation is limited to either the secreted products of 
the conceptus or to the time around implantation. Research suggests that the proteins secreted 
from the conceptus aid in its attachment to the uterus. The ECM, specifically fibronectin, plays a 
role in the early development and attachment to the uterine surface of bovine embryos (Larson et 
al., 1992). 
The pregnant bovine endometrium expresses integrin subunits 1, 3, and 6 as well as 
their ligand, integrin β1 subunit, in the epithelium of the endometrium. Along with these are 
ECM proteins, collagen IV and laminin, which are increased around the time of attachment in 
the uterus compared to during normal cyclicity. As the attachment of the bovine trophectoderm 
to the uterine epithelium proceeds, expression of these adhesion molecules changes. The 
trophectoderm down-regulates integrin subunit 1 but increases 6 from days 18-24 of gestation. 
Uterine epithelium constitutively expressed α3 and α6 integrin subunits, but 1 was down-
regulated as the luminal epithelium was modified. Collagen IV and laminin reactivity increased 
in the basal lamina and underlying subepithelial stroma as pregnancy proceeded. Binucleate cell 
fusion with the maternal epithelium initiates integrin and ECM changes in the subepithelial 
stroma (MacIntyre et al., 2002). 
Conceptus Secretory Proteins 
The IFNT induces expression of classical and nonclassical interferon-stimulated genes 
(ISGs) in the cellular compartments of the endometrium that are proposed to regulate conceptus 
elongation (Mansouri-Attia et al., 2009, Bazer et al., 2008, Bauersachs et al., 2006, Forde et al., 
2011). The conceptus also produces prostaglandins on Day 13 that can modify the endometrium 
prior to pregnancy recognition (Spencer et al., 2013). In a study analyzing Day 16 conceptus 
9 
 
culture medium, 1005 proteins, including IFNT, were detected within 6 h of culture. A 
comparison of the proteins in the 6 h and 24 h culture media resulted in identification of 875 
proteins in common compared to uterine luminal fluid (ULF) of cyclic heifers, and 30 proteins 
that were unique to ULF from Day 16 pregnant heifers and were also produced by the Day 16 
conceptus after 6 h and 24 h of culture. Ten of the conceptus derived proteins were considered to 
influence genes that were modified in the endometrium during pregnancy recognition. Five 
conceptus derived proteins were considered to influence genes that were down-regulated in the 
endometrium of pregnant heifers compared to cyclic heifers, while nine conceptus-derived 
proteins interacted with genes that were upregulated in pregnant compared to cyclic 
endometrium during pregnancy recognition (Forde et al., 2015). 
Bovine trophoblast cells produce a number of hormones and growth factors including P4, 
bPL, pregnancy-associated glycoproteins (bPAG), and transforming growth factor beta, and 
many more genes (Munson et al., 1996). The bPAGs have been localized to binucleate cells, and 
are expressed during early pregnancy (Patel et al., 1997). Pregnancy detection methods have 
been developed utilizing the presence of bPAGs thus far as early as 28 days after insemination 
(Pohler et al., 2016). Peripheral systemic levels of bPAG have been shown to increase over the 
last 10 days of pregnancy (Patel et al., 1997). Around this time is also when marked binucleate 
cell degranulation occurs. It has been suggested that bPAG-1 is a proteinase, but its specific role 
in placental release is not known (Roberts et al., 1995).  
Early Embryonic Loss 
Early embryonic loss greatly affects the cattle industry. Specifically, in dairy herds 
reproductive efficiency is suboptimal and the act of improving reproduction can increase the 
profitability of dairy operations. Many factors can affect early embryonic loss including but not 
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limited to, environmental factors, genetics, and management. In heifers and moderate-producing 
dairy cattle, fertilization rates are generally high (90–100%) after natural mating or AI 
(Mapletoft, 2013). Cattle experience a high rate of pregnancy loss between fertilization and 
calving, that ranges from 40% to 56% (Diskin et al., 2006, Sreenan et al., 1986, Wiltbank et al., 
2016, Spencer et al., 2017, Diskin and Morris, 2008). Beef cattle have an embryonic and fetal 
mortality rate of approximately 40% based on an average calving rate of 55%.  Pregnancy loss is 
important to the cattle conceptus transfer (ET) industry, in which more than 750,000 embryos are 
produced annually from superovulated donors and more than 450,000 embryos are produced 
using in vitro techniques (Mapletoft, 2013). Indeed, 485,595 in vivo-derived and 364,727 in 
vitro-produced bovine embryos were transferred commercially worldwide in 2014 (Perry, 2015). 
Mean survival rate to calving following the transfer of in vivo-derived embryos from 
superovulated donors ranges from 31% to 60%, whereas the mean survival rate after transfer of 
in vitro-produced embryos is lower and ranges from 30% to 40% (McMillan, 1998, Hansen and 
Block, 2004). There are four pivotal periods of loss during the first trimester of pregnancy.  
The first of which occurs the first week after breeding with lack of fertilization or death 
of the early embryo. Between 10% and 50% of potential pregnancies are lost during this 
period.  Decreasing pregnancy loss during this period targets improving oocyte quality by 
eliminating heat stress, inflammatory diseases, and body condition loss. Pregnancy loss during 
this time could also be decreased by adjusting circulating progesterone concentrations during 
preovulatory follicle growth, reducing the size of the ovulatory follicle, reducing heat stress, and 
improving the metabolic state of the lactating dairy cows.  
The second pivotal period is from days 8 to 27 of pregnancy, during the conceptus 
elongation and maternal recognition of pregnancy phases.  This being said, maternal recognition 
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of pregnancy occurs from days 16-25 in cattle while a definitive pregnancy diagnosis can be 
made on day 28. The critical period for maternal recognition of pregnancy in cattle is about day 
16 after estrus. Embryos transferred on day 16 were able to maintain a pregnancy while embryos 
that were transferred on day 17 or later were not able to maintain pregnancy (Betteridge et al., 
1980). During this time the conceptus undergoes elongation of its trophoblast cells while 
secreting bINF-T and other regulatory factors that alter the uterine endometrium to cause cells to 
produce and/or transport growth factors, and nutrients for embryonic nutrition and elongation. 
Interferon-T signals the conceptus’ presence to the maternal system which allows for the 
suppression of the maternal immune system, maintenance of the CL, P4 concentrations to remain 
high, and conceptus elongation.  Suboptimal patterns of circulating P4 can lead to altered gene 
expression in uterine endometrial cells, suboptimal growth of the embryo, and reduced 
pregnancy success. Failure of the conceptus, uterus, or ovaries to communicate at this stage will 
result in luteolysis, reduced P4, return to cyclicity, and early embryonic mortality (Wiltbank et 
al., 2016).  
The third pivotal period occurs between days 28 and 60. During this time placentomes 
will develop and the conceptus will also develop allantoic tissue, leading to adherence and later 
attachment to the maternal membranes. Risk factors at this point include inadequate placentation, 
difficulty in the transition of nutrition, alterations in vascularization of the placenta, 
underdevelopment of the embryo/fetus, disease, metabolic dysfunction, and irregular hormonal 
conditions.  Pregnancy losses during this period are estimated to be 12% in dairy cattle 




Galectins are a phylogenetically conserved group of lectins composed of approximately 
130 amino acids with a carbohydrate recognition domain (CRD) responsible for binding to B-
galactosides. Thus far, 19 galectins have been identified and can be organized into three groups 
based on the CRD structure (Barrientos et al., 2014). The “prototype” galectin, or dimeric 
galectin, encompasses most mammalian galectins (galectins-1,-2,-5,-7,-10,-13,-14,-15,-16,-17,-
19,-20). These prototype galectins are most commonly homodimers of two identical galectin 
subunits although they can also function as monomers. The “tandem-repeat-type” galectins 
(galectins-4,-6,-8,-9,-12) consist of two homologous CRDs linked by a small peptide domain, 
which allows for multivalent binding. Galectin-3 (LGALS3), the only type-3 galectin, possesses 
a carboxy-terminal CRD and an amino-terminal non-lectin domain. The N-terminal domain 
allows for multimerization and crosslinking between galectin proteins, each containing a CRD. 
As a result, LGALS3 is referred to as chimeria-type and may form lattices between tissues 
(Camby et al., 2006).  
Galectin proteins are primarily in the cytoplasm. Galectins lack a secretory signal 
sequence but can be transported from cells in a non-classical secretory fashion. In this process, 
galectins are incorporated into intracellular vesicles under the plasma membrane and are 
secreted, but avoid the endoplasmic reticulum and golgi vesicles. They then gather on the cell 
surface to form lipid rafts and crosslink with receptor ligands. This type of secretion is increased 
in response to cellular stress and damage. They can be used as stress sensors, or alarmins, that 
can signal tissue damage and elicit immune cells to activate or resolve an immune response 
(Barrientos et al., 2014). 
Galectins do not have specific receptors, therefore, they bind to a variety of cell- surface 
or ECM molecules which carry their carbohydrate ligands. Most members of the galectin family 
13 
 
thus far bind simple beta-galactosides, such as disaccharides or trisaccharides, but the affinity is 
relatively weak. When galectins bind to natural glycoconjugate ligands expressed on cell 
surfaces or in the ECM they usually bind with a much higher affinity. (Cummings and Liu, 
2009). 
 By binding these distinct glycans on cell surfaces, they form a lattice of galectin-glycan 
bonds and effects cell growth, survival, metabolism, cytokine secretion, and cell-cell/ECM 
interactions. Various galectins have been shown to influence cell adhesion, induce or prevent 
apoptosis, and due to their cytokine-like properties, are major activators or inhibitors of immune 
responses (Than et al., 2012).    
Galectin-1 
Galectin-1 (LGALS1) was the first galectin discovered and is encoded by the gene 
LGALS1, which is located on chromosome 22 of cattle. Galectin-1 is a protein of 135 amino 
acids and functions as a prototypic galectin that can form monomers and homodimers. The 
monomer CRD has a “jelly roll” folding structure with five to six stranded antiparallel β-sheets 
arranged in a β-sandwich. At high concentrations, LGALS1 can be found as a non-covalent 
dimer with interactions at the carboxy- and amino-terminal domains of each subunit leaving the 
glycan binding sites in the CRD located at opposite ends. Like other galectin family members, 
the LGALS1 CRD binds to beta-galactosides including lactose and N-acetyl-d-lactosamine 
(Barrientos et al., 2014), as well as other ligands like the carbohydrate portion of ganglioside 
GM1 (Kopitz et al., 1998). This protein functions intracellularly with protein-protein interactions 
and extracellularly with N-acetyllactosamine interactions (Barrientos et al., 2014, Liu et al., 
2002). Galectin-1 has effects on many cell-signaling pathways such as cell growth, adhesion, 
motility, and invasion. 
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Galectin-1 is mitogenic for both normal and pathological cells in mice and humans such 
as murine thymus cell antigen 1 (Thy-1) negative spleen or lymph node cells, mammalian 
vascular cells, and hepatic stellate cells (Maeda et al., 2004, Sanford and Harris-Hooker, 1990, 
Moiseeva et al., 2000). It also inhibits the growth of cells such as neuroblastoma and stromal 
bone marrow cells (Andersen et al., 2009, Kopitz et al., 1998). The action of LGALS1 is dose 
dependent; when given in high doses LGALS1 will inhibit cell proliferation independently of 
LGALS1 sugar binding activity, while low doses are mitogenic and susceptible to inhibition by 
lactose (Adams et al., 1996, Vas et al., 2009). The positive and negative effects of LGALS1 on 
cell type and cell activation status are influenced by the relative distribution of monomeric and 
dimeric forms, and intracellular and extracellular forms (Camby et al., 2006).  
Galectin-1 increases the adhesion of normal and cancer cells to the ECM by cross-linking 
various glycoproteins, such as β1 integrins, exposed on the cell surface. Galectin-1 also can 
regulate atypical cell interactions such as those between cancer cells and endothelium, causing 
the dispersion of tumors. Galectin-1 causes increased motility of glioma cells and reorganization 
of the actin cytoskeleton while the knockdown of LGALS1 expression in glioma cells reduces 
motility and adhesiveness. By using highly and poorly invasive mammary carcinoma cell lines, it 
was shown that the membrane expression of LGALS1 was a mark of cell invasiveness (Camby 
et al., 2006). 
Galectins in Pregnancy 
In women, LGALS1 expression is regulated by steroid hormones and varies during the 
menstrual cycle and early phases of gestation. Progesterone and E2 increase LGALS1 mRNA 
levels while blocking the P4 receptor (PGR) and estrogen (ER) reduced this effect (Diep et al., 
2016). In delayed implantation experiments in mice, E2 together with P4, but not P4 alone, 
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increased uterine LGALS1 expression suggesting that LGALS1 may be important for uterine 
receptivity (Choe et al., 1998). Crosstalk between LGALS1 and P4 is important for the 
establishment and maintenance of immune tolerance during pregnancy through endocrine and 
immune-mediated mechanisms (Diep et al., 2016). In vivo experiments in mice demonstrated 
that LGALS1 increases circulating levels of P4 and progesterone-induced blocking factor 
(PIBF), which mediate the effects of P4 and exerts pregnancy-protective effects by promoting a 
T-helper (Th) 2-type cytokine profile. Reciprocally, the LGALS1 expression is up-regulated in 
stromal and decidua cells after supplementary administration of a P4 derivative (Barrientos et al., 
2014, Blois et al., 2007, Blois et al., 2004, Arck et al., 2007) 
Expression of LGALS1 has been detected in day 3 and day 5 human trophectoderm. 
Human conceptuses also secrete LGALS1 into the medium in which they are cultured, 
suggesting that the extracellular functions of this lectin are important for uterine blastocyst 
attachment during the window of implantation. This may be initiated through LGALS1 binding 
of mucin 1 (MUC1) via the transcription factor (TF) epitope (Jeschke et al., 2009). Similarly the 
mouse trophectoderm also expresses LGALS1 that promotes attachment and invasion functions 
to the uterine wall during the implantation period (Poirier et al., 1992). Studies profiling 
LGALS1 in the female reproductive tract led to the hypothesis that the balanced action of 
maternal and fetal sources of expression is most critical for healthy gestations. Maternal 
LGALS1 has been implicated in the process of decidualization, the transformation of 
endometrial stroma into a specialized tissue that supports trophoblast invasion and provides 
nourishment to the conceptus before the establishment of a definite placenta (Ramathal et al., 
2010).  In humans, LGALS1 expression is elevated during endometrial stromal cells 
decidualization. Further, the LGALS1 expression is increased in the decidua of the first trimester 
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of pregnancy (von Wolff et al., 2005, Bevan et al., 1994). Mice differ slightly because their 
decidualization is triggered by the attachment of the conceptus but is otherwise similar in the 
distribution of endometrial LGALS1 expression. Galectin-1 is expressed in all uterine tissues 
except the glandular and luminal epithelium and is particularly strong in the cytoplasm of 
decidualized stromal cells (Barrientos et al., 2014). Galectin-1 expression increases significantly 
in the late secretory phase of the human endometrium. Galectin-1 is expressed in decidual tissue 
and trophoblastic tissue. During the first trimester of human gestation, LGALS1 is expressed in 
connective tissue, smooth and striated muscle, and some epithelia such as the skin, gonads, 
thyroid, and kidneys. Galectin-1 has been shown to have effects on nerve structure development, 
differentiation of hematopoietic lineage, and differentiation of the myogenic lineage (Camby et 
al., 2006, von Wolff et al., Maquoi et al., 1997, Vićovac et al., 1998). 
Galectin-1 and the Immune system 
Galectins, especially LGALS1, are immensely involved in the initiation, amplification, 
and resolution of inflammatory responses (Camby et al., 2006). The effects of LGALS1 on the 
innate and adaptive immune system are consistent with its role as a tolerogenic and anti-
inflammatory signal through its mechanisms of tumor immune evasion and autoimmune 
diseases. Galectin-1 assists the decidua of pregnancy in the modulation of inflammation and 
immune cell activation where it hosts an environment that prevents damage to the developing 
fetus while retaining the ability to protect the mother from infections (Camby et al., 2006).  
Based on cytokine production, Th cells are classified into Th1 and Th2. Th1 cells 
generate cytokines such as interferon (IFN)-γ, interleukin (IL)-1β, and tumor necrosis factor 
(TNF)-α, and support cell-mediated immunity. Th2 cells produce IL-4, IL-5, and IL-10, and 
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down-regulate Th1 responses. Th1 cytokines inhibit the outgrowth of trophoblast cells (Corthay, 
2009).  
Galectin-1 seems to be essential for maintaining the balance between pro-inflammatory 
Th-1 and tolerogenic Th2 cytokines needed for a successful pregnancy. This effect has been 
demonstrated in the mouse model of immunological abortions by Blois et al. (2007) as an 
increase in fetal loss rate caused by the increase of abortogenic Th1 cytokines due to stress. 
These stress challenged mice exhibited a decrease in decidual LGALS1 expression, and by 
supplementation of LGALS1 protein during early pregnancy, they were able to prevent fetal 
rejection. Blois et al. (2007) hypothesized that LGALS1 restored the Th1 to Th2 cytokine ratio 
of decidual mononuclear cells (Barrientos et al., 2014, Blois et al., 2007).  
Placental LGALS1 expression was higher in women with severe preeclampsia when 
compared to normal pregnant women. The authors concluded that increased expression of 
LGALS1 in preeclampsia patients may represent a fetal response to an exaggerated systemic 
maternal inflammation and that LGALS1 may be implicated in maternal-fetal immune tolerance 
in humans (Than et al., 2008). 
It has been suggested that LGALS1 is able to regulate the Th1 to Th2 cytokine ratio 
through the process of positive and/or negative selection within the thymus. Galectin-1 is able to 
induce the differentiation of tolerogenic cluster of differentiation (CD) 11c dendritic cell (DCs) 
that in turn promotes the expansion of IL-10 producing CD4+CD25+ regulatory T cells (Blois et 
al., 2007). Galectin-1 null mice display exacerbated Th1 and Th17 responses and a higher 
frequency of immunogenic DC compared to the wild type (WT) counterpart. They were able to 
reproduce normally when mated but showed increased fetal loss rates and enhanced 
susceptibility to stress-induced abortions (Garin et al., 2007).  
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Galectin-1 also suppresses the secretion of the pro-inflammatory cytokine interleukin-2 
(IL-2) (Garin et al., 2007). It induces the inhibition of cell growth and cell cycle arrest and 
promotes the apoptosis of activated, but not resting, immune cells. Dimeric LGALS1 is more 
potent in inducing apoptosis in T-cells than wild-type LGALS1 in vitro (Bättig et al., 2004).  The 
effects of LGALS1 on immune cells are likely due to the binding and crosslinking of cell surface 
glycoproteins on cells. When present as a dimer, LGALS1 binds to glycoproteins on the surface 
of T-cells in a carbohydrate-dependent manner (CD2, CD3, CD7, CD43, and CD45). In vivo 
studies have discovered the capability of LGALS1 to shift the balance toward a Th2-type 
cytokine response by reducing the levels of IFNγ, TNFα, IL-2, and IL-12 while increasing IL-5 
secretion (Camby et al., 2006, Bättig et al., 2004). 
Found in the bovine placenta are fetal macrophages, also referred to as “Hofbauer cells” 
(Benirschke and Kaufmann, 1995). Fetal placental macrophages may originate either from 
chorionic mesenchyme early in gestation or from fetal bone marrow-derived monocytes. These 
cells produce pro-inflammatory cytokines and function in antigen presentation suggesting that 
they can serve as the first line or an important mediator of defense and may contribute to the 
transplacental transmission of microbial agents (Schlafer et al., 2000). 
Pregnancy losses in cows due to increased Th1 cytokine production during inflammation 
or immune activation have been reported (Maeda et al., 2013). Previous studies have found that 
P4 inhibited the expression of IFN-γ and IL-17 dose-dependently in both pregnant and non-
pregnant cows and strongly inhibits the differentiation of Th cells into Th1 and Th17 especially 
in the pregnant cows. Progesterone significantly increased the expression of IL-4 only in 
pregnant cow endometrium has a high level of the Th2 cell transcription factor, GATA-3, 
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indicating that early pregnancy in cattle is associated with a skew towards Th2 immune cell 
profile (Maeda et al., 2013). 
Galectin-1 findings in cattle 
Galectin-1 expression was shown to be 2.93 fold higher in blastocysts produced in vivo 
compared to in vitro produced (IVP) blastocysts (Mohan et al., 2004). Expression of LGALS1 by 
the pre-attachment conceptus may function to protect the implanting conceptus from the harmful 
effects of the maternal immune system. Reduced expression of LGALS1 by IVP embryos may 
be partially responsible for the high embryonic loss and poor pregnancy rates following the 
transfer of IVP embryos (Mohan et al., 2004). Galectin-1 receptors/binding proteins have been 
found on the conceptus and endometrium on day 16 of gestation (Mamo et al., 2012). There was 
also reduced expression of LGALS1 in the endometrium of low fertility dairy heifers (Killeen et 
al., 2014).  
A study by R. Froehlich et al. (2012) showed LGALS1 was present at the fetal-maternal 
interface of the placentome. Through the techniques of immunohistochemistry (IHC), LGALS1 
was localized to fibrocytes of the maternal lamina propria and monocytes of the uterine vessel 
walls. In the fetal smooth chorion, mononuculeate trophoblast cells showed weak staining in 
some areas during the late implantation period (day 30-60) but the intensity of the staining 
increased until day 100, then decreased until the end of gestation. Trophoblastic giant cells 
showed strong staining in the implantation period and early pregnancy until day 100 and was not 
reactive past that time. In the placentome, the maternal connective tissue was weakly stained, 
which increased steadily after day 180. The smooth muscle cells of the vessel walls in the 
maternal and fetal compartment showed a uniform reaction. In early gestation, fetal endothelia in 
the vicinity of the maternal compartment displayed weak staining intensity, which increased 
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continuously during mid and late gestation. In contrast to interplacentomal tissue, the caruncular 
epithelium in the placentome was positive throughout the course of pregnancy. The same applied 
to uninucleate trophoblast cells. In many TGC, LGALS1 was present in early pregnancy. 
However, the number of positive cells decreased with progressing gestation stage until day 270 
when TGC was negative (Froehlich et al., 2012).  
Galectin-1 was found to be a differentially expressed gene in the endometrium of AI 
pregnant cows when compared to cyclic cows. In vitro cell culture experiments of endometrial 
fibroblasts and glandular epithelial cells treated with IFNT showed that C11ORF34, LGALS1, 
and SCARA5 were not regulated by IFNΤ in either type of endometrial cell cultures. In situ 
hybridization was performed on the pregnant and cyclic endometrium and it was observed that 
LGALS1 expression was prominent in the stroma of cyclic and pregnant cows, but the staining of 








EFFECT OF GALECTIN-1 ON ANTI-INFLAMMATORY AND PRO-INFLAMMATORY 




Early embryonic mortality, a major cause of pregnancy failure in cattle, may result from 
inappropriate maternal immune responses to the conceptus. Galectin-1 (LGALS1), an immune-
modulatory protein, secreted by the bovine conceptus. Studies suggest LGALS1 increases 
expression of genes associated with regulatory T cells (Treg) and anti-inflammatory proteins 
within the bovine caruncle. The present study investigated the effect of LGALS1 on the 
expression of genes related to Treg and anti-inflammatory (FOXP3, IL-2RA, CD11c, and IL-10) 
as well as pro-inflammatory (CXCR4, LIF, IL-33, IL-1B, and IL-6) activities in inter-caruncular 
endometrium. Bovine inter-caruncular endometrial explants were collected from uteri (n=4) 
during the mid-luteal phase of the estrous cycle and cultured in Roswell Park Memorial Institute 
Medium (RPMI) media containing 0, 10, 100, or 1000 ng/mL of recombinant bovine LGALS1 
for 6 or 24 h. Explant mRNA abundance was then determined using RT-qPCR. A MIXED 
procedure in SAS was utilized to analyze the data. A contrast statement was included comparing 
control to all LGALS1 treatments. Treatment did not affect the expression of IL-33. At 6 h, there 
was an effect of treatment on IL-10 (P ≤ 0.01), LIF, IL-1B, and IL-6 (P ≤ 0.001) mRNA. At 24 h, 
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there was an effect of treatment on CXCR4, CD11c, IL-2RA, FOXP3 (P ≤ 0.05), IL-10, LIF (P ≤ 
0.01), IL-6, and IL-1B (P ≤ 0.001) mRNA. Expression in both pro- and anti-inflammatory genes 
increased with increasing concentration of LGALS1. Thus, bovine conceptus-derived LGALS1 
may have important functions in the regulation of the maternal immune environment prior to 
implantation by inducing a balance of pro-inflammatory and anti-inflammatory states. 
INTRODUCTION 
In the cattle industry, reproductive success drives profitability and early embryonic is a 
large contributor to the economic loss in animal agriculture (Bellows et al., 2002, Wiltbank et al., 
2016). Following fertilization, the conceptus enters the uterus approximately 5 days later. 
Starting near day 13, the bovine conceptus begins to rapidly elongate into a long, filamentous 
structure. On day 13, the conceptus is approximately 5.3 mm in length. By day 16, the conceptus 
will be approximately 52mm in length (Grealy et al., 1996). During elongation the conceptus 
secretes interferon-tau (IFNT), which disrupts luteolysis and prevents the CL from regressing 
thus, providing adequate concentrations of progesterone (P4) to support pregnancy (Spencer et 
al., 2017). This process is termed as maternal recognition of pregnancy. As the conceptus 
develops and elongates, it also increases the production of conceptus secretory proteins (CSP), 
many of which are uncharacterized (O'Hara et al., 2013).  Galectins, a conserved group of lectins 
that are characterized by their carbohydrate recognition domain (CRD), are considered bovine 
CSP. The galectin CRD on the galectins bind to N-acetyllacosamine saccharide ligands on the 
cell surface. There are three classifications of galectins, type 1, 2, and 3 based on their CRD. 
Type 1 galectins are biologically active as homodimers while type 2 form heterodimers and type 
3 are active as a chimera (Barrientos et al., 2014). In rodents, LGALS1, a type 1 galectin, 
reduced fetal loss in sound stressed mice (Blois et al., 2007). The LGALS1 effects were 
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attributed to suppression of the endometrial immune system during implantation. Specifically, 
LGALS1 increased endometrial tolerogenic dendritic cells characterized by expression of 
CD11c, also known as ITGAX, and regulatory T-cells (Treg) that express CD4, FOXP3 and IL-
2RA (Blois et al., 2007). In cattle, LGALS1is present in the conceptus as well as caruncular and 
intercaruncular regions of pregnant bovine endometrium, specifically the maternal stroma, at all 
stages of gestation (Froehlich et al., 2012). The LGALS1 also was found to be expressed by the 
endometrium and early bovine conceptus as early as day 16 of gestation (Mansouri-Attia et al., 
2009, Mamo et al., 2012, Forde et al., 2015). Further, studies have shown reduced LGALS1 
expression in in vitro produced blastocysts compared to in vivo produced bovine blastocysts, 
which could be cause for high embryonic loss and poor pregnancy rates following transfer of an 
in vitro produced blastocyst (Mohan et al., 2004).  Galectin-1 relative mRNA expression was 
also reduced in the endometrium of low fertility dairy heifers and was found to be involved in 
cellular growth and proliferation, cell death, cell morphology, small molecule biochemistry, and 
lipid metabolism through integrated pathway analysis (IPA) analysis. Thus, LGALS1 may have 
important functions during early gestation in cattle (Killeen et al., 2014). The precise role of 
LGALS1 during early pregnancy in cattle is unknown. Based on rodent studies and information 
presented in Chapter IV, LGALS1 may increase expression of both Treg and anti-inflammatory 
genes as well as pro-inflammatory related genes within the endometrium. Many of these genes 
are thought to be important for the establishment of pregnancy in mammals. This study 
investigated their expression in bovine endometrial explants in response to increasing 
concentrations of LGALS1.  




Reproductive tracts (n=4) in the mid-luteal phase of the estrous cycle, based on the 
classification described by (Ireland et al., 1980), were collected from a local abattoir and placed 
on ice and transported to the laboratory (within approximately 1 h of slaughter). Intercaruncular 
endometrial explants were prepared as described (Borges et al., 2012).  In the laboratory, the 
uterine horn ipsilateral to the CL was dissected longitudinally to expose the endometrium. The 
endometrium was washed with pre-warmed (38.8°C) 1% PBS containing 1% anti-biotic anti-
mycotic (ABAM; Gibco, Gaithersburg, MD). An 8 mm biopsy punch was used to dissect the 
intercaruncular tissue from the middle third of the uterine horn. Using sterile scissors, the 
myometrium was dissected, and the endometrial explants (50-80 mg) were then washed in 25 
mL of Hank’s Balanced Salt Solution (HBSS; Gibco) containing 1% ABAM. Explants were then 
placed in culture wells (6-well plates; one explant/well) containing 3 mL of RPMI (pre-treatment 
medium,Gibco) containing 1% ABAM. Explants were cultured endometrial side up in 5% CO2 
at 38.8°C for approximately 1 h before treatment. At treatment, pre-treatment media was 
removed and explants were treated with treatment media alone (Control) or treatment media 
containing 10, 100, or 1000 ng/mL of recombinant bovine LGALS1 (Cusabio, Houston, TX). 
The explants were treated for 6 or 24 h at 38.8°C at 5% CO2. All treatments were applied to each 
uterus. After treatment, explants were cut in half, and one half of the explant was snap frozen in 
liquid nitrogen and stored at -80°C until RNA extraction and the other half was fixed in 10% 
neutral buffered formalin (NBF).  
Explant RNA Extraction 
Total RNA extraction was carried out as described by Forde et al. (2009). Briefly, total 
RNA was extracted from ~50 mg of endometrial explant tissue using Trizol reagent (Invitrogen, 
Carlsbad, CA) per the manufacturer´s instructions. On-column RNA clean-up was performed 
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using the Qiagen mini kit (Qiagen, Hilden, Germany). The quantity and quality of RNA samples 
were determined using the Nano Drop 1000 (Thermo Fisher Scientific, Waltham, MA) and the 
Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA), respectively. The RNA integrity 
number (RIN) ± the standard deviation was 7.4 ± 0.3.  
RT-qPCR 
Explant mRNA (500ng) was reverse transcribed into cDNA using the High-capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA), and cDNA samples 
were diluted 1:20 in nuclease free water. Reactions were 20 μL including 10 μL of PowerUP 
SYBR Green Master Mix (Bio-Rad; Hercules, CA), 1.2 μL of each primer, and 2.6 μL of DNase 
RNase free water, and 5 μL of sample following the manufacturer’s instructions. No reverse 
transcriptase controls were included. The RT-qPCR reactions were carried out using PowerUp 
SYBR Green Master Mix (Applied Biosystems) and the CFX96 Touch Real-Time PCR 
Detection System (Bio-Rad, Hercules, CA) following the manufacturer’s recommendations. All 
samples were analyzed in duplicate and no reverse transcriptase controls and no template 
controls were included. Primers were created using Primer3Plus or obtained from previously 
published research. The PCR primer amplification efficiencies (E; E = [10(-1/slope) -1]) for each 
PCR target sequence were calculated from the standard curve generated from seven cDNA 
dilutions made from a pool of cDNA samples. Diluted in a buffer containing 1% 100X Tris 
EDTA (Sigma Aldrich) 0.4% lambda DNA (Invitrogen, Carlsbad, CA) and DNase and RNase 
free water. Dilutions were 1:1, 1:4, 1:16, 1:64, 1:256, 1:1024, 1:4096, respectively. Slope 
generated from plotting Ct values against dilution for each serial dilution. Percent primer 
efficiency was calculated by dividing E by 2 and then multiplying by 100. Only primers with 
efficiencies between 90-110% were used. A dissociation analysis was included for each primer 
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pair to evaluate primer specificity for the target sequence. Gel electrophoresis was used to 
confirm the primer pair by amplicon size.  
Qbase+ qPCR analysis software (Biogazelle, Zwijnaarde, Belgium) was used to calculate 
the normalized relative expression quantities (NRQ) of target genes based on a generalized delta-
delta quantification cycle method (ΔΔCq; also known as ΔΔCT) (Hellemans et al., 2007). To 
identify potential normalization targets, RT-qPCR was carried out for eight potential genes 
across a subset of samples representing all treatments. Tyrosine 3-monooxygenase/ tryptophan 5-
monooxygenase activation protein zeta (YWHAZ) and peptidyl-prolyl isomerase A (PPIA) were 
the most stably expressed across treatments using the geNorm analysis (geNorm M < 0.25; 
Vandesompele et al., 2002). The RT-qPCR thermo cycler settings for all reactions consisted of 
an initial temperature of 50°C for 2 min, 95°C for 2 min followed by 40 PCR cycles consisting 
of melting at 95°C for 15 sec and annealing and extension at 60°C for 1 min. Genes H3 histone 
family member 3A (H3F3A) and succinate dehydrogenase complex flavoprotein subunit A 
(SDHA) were found to be the most stably expressed across treatments using the geNorm analysis 
(geNorm M < 0.25) (Vandesompele et al., 2002). The RT-qPCR thermo cycler settings for all 
reactions consisted of an initial temperature of 50°C for 2 min, 95°C for 2 min followed by 40 
PCR cycles consisting of melting at 95°C for 15 sec and annealing and extension at 60°C for 1 
min.  
Statistical Analysis 
A mixed procedure in the statistical analysis software (SAS) was used to analyze for an 
effect of treatment on the log base 10 (log10) explant relative expression data. A Tukey-Kramer 
adjustment was included for multiple comparisons. One contrast compared Control to all 
LGALS1 treatments (10, 100, 1000 ng/mL). Data residuals were scrutinized for normality using 
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the PLOTS=(diagnostics residuals) statement. All relative expression values are presented in 
their original format; however, all p-values are that of the log10 transformation. If log10 
transformed residual data were not normally distributed, they were transformed by squareroot 
(sqrt) transformation. Data are presented as least squares means ± standard error of the least 
squares mean (LSM ± SEM). Statistical significance was declared at P ≤ 0.05. 
RESULTS 
Intercaruncular mRNA Expression of Regulatory T-cell Related Genes 
Treatment affected endometrial relative gene expression of FOXP3 at 24 h compared to 
control (Figure 3.1; Control, 10, 100 and 1000 ng/mL LGALS1; LSM + SEM; 0.57, 0.75, 0.78 
and 0.75 ± 0.23; P < 0.05). Treatment increased the endometrial relative expression of IL-2RA at 
24 h compared to Control (Figure 3.3; 0.54, 0.65, 1.00 and 1.26 ± 0.33; P < 0.05). 
Intercaruncular mRNA Expression of Anti-Inflammatory Related Genes 
Treatment affected endometrial relative gene expression of IL-10 at 6 h and 24 h 
compared to Control (Figure 3.2; 6 h 1.15, 1.40, 2.21 and 2.76 ± 0.41; P < 0.01; 24 h 0.52, 0.52, 
0.70 and 0.91 ± 0.14; P < 0.01). There was a tendency for treatment to affect endometrial gene 
expression of CD11c at 24 h (Figure 3.4; 0.77, 0.91, 1.21 and 1.37 ± 0.17; sqrt transformation; P 
= 0.06). 
Intercaruncular mRNA Expression of Pro-Inflammatory Related Genes 
There was an effect of treatment on endometrial relative expression of IL-1B at 6 h and 
24 h. Expression of IL-1B mRNA at 6 h was greater when all LGALS1 treatments were 
compared to Control (Figure 3.5; 0.33, 0.70, 1.34 and 2.54 ± 0.31; sqrt transformed; P < 0.001), 
Expression of IL-1B mRNA at 24 h was greater when all LGALS1 treatments were compared to 
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Control (Figure 3.5; 0.50, 1.24, 2.90 and 2.66 ± 0.43; P < 0.001). There was an effect of 
treatment on endometrial relative gene expression of LIF at 6 h and 24 h. Expression of mRNA 
was greater when all LGALS1 treatments were compared to Control (Figure 3.6; 0.44, 0.65, 1.10 
and 1.91 ± 0.17; P < 0.001). Endometrial relative expression of LIF mRNA at 24 h was greater 
when all LGALS1 treatments were compared to Control (Figure 3.6; 0.65, 1.20, 1.43 and 2.13 ± 
0.28; sqrt transformed; P < 0.01). There was an effect of treatment on endometrial relative gene 
expression of IL-6 at 6 and 24 h. Expression of IL-6 mRNA was greater when all LGALS1 
treatments were compared to Control for 6 h (Figure 3.7; 0.34, 1.12, 4.07 and 6.98 ± 1.09; P < 
0.001) and 24 h (Figure 3.7; 0.23, 0.61, 1.10 and 1.77 ± 0.20; P < 0.001). There was an effect of 
treatment on endometrial expression of CXCR4 at 24 h. Expression of CXCR4 mRNA was 
greater when all LGALS1 treatments were compared to Control (Figure 3.8; 3.10, 4.00, 4.50, 
4.20 ± 0.52; P < 0.05). 
DISCUSSION 
Expression of LGALS1 has been found in the trophectoderm of human preimplantation 
embryos as well as in the mouse uterus during implantation (Choe et al., 1997), Tirado-Gonzalez 
et al., 2013). Evidence suggests that human LGALS1 plays important roles in implantation, 
angiogenesis, maternal-fetal immunotolerance, and placentation (Bojić-Trbojević et al., 2015). 
Studies have shown expression of LGALS1 in the bovine day 7 blastocyst and in the conceptus 
and endometrium on day 16 of gestation (Mamo et al., 2012, (Forde et al., 2015), Mansouri-Attia 
et al., 2009). However, the effect of LGALS1 within the bovine endometrium has not been 
investigated. 
The aim of this study was to investigate the role of bovine conceptus LGALS1 in bovine 
endometrium with a specific emphasis on Treg and anti-inflammatory as well as pro-
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inflammatory gene expression. Our findings indicate increased gene expression of Treg markers 
such as IL-2RA and FOXP3, and tolerogenic dendritic cell (DC) marker CD11c with increasing 
concentrations of LGALS1.  
Galectin-1 has been described as a pro-adhesive molecule (Barrientos et al., 2014). 
Recently, research has pointed to LGALS1 also being a regulator of immune responses during 
pregnancy (Blois et al., 2007). In mice and humans, LGALS1 selectively induces apoptosis of 
pro-inflammatory Th1 and Th17 cell subsets but not naïve Th2 or Treg (Toscano et al., 2007). A 
particular Th subset of interest is Treg which includes CD4+ T cells that co-express high levels 
of CD25 (IL-2RA) and the transcription factor FOXP3. This particular phenotype has been 
identified in the human and mouse (Tan et al., 2011, Jonuleit et al., 2001, Baecher-Allan et al., 
2001, Klages et al., 2010). Research has shown that Tregs promote immunosuppression. Data 
suggest that IL-10 and TGF- β are important mediators of Treg activity. In a study to investigate 
the Treg-specific immunosuppressive molecules in mice and humans, LGALS1 was identified as 
a significantly expressed and secreted by Tregs. The investigator also showed that Treg 
immunosuppressive activity was blocked by the use of anti-LGALS1 in vitro (Garin et al., 2007).  
In a previous study, LGALS1 reduced fetal loss in sound stressed rodents (Blois et al., 
2007). The author found that LGALS1 increased the presence of Treg in the uterus and 
hypothesized that LGALS1 was promoting fetomaternal tolerance. When the presence of Treg 
was reduced, the effects were abrogated and there was a higher percentage of fetal loss. The 
author also suggests that LGALS1 may act upstream of IL-10 to promote fetal survival by 
increasing CD11c tolerogenic dendritic cell activity. Through these findings, we can conclude 
that LGALS1 plays a pivotal role in the fetomaternal tolerance through modulation of multiple 
immunoregulatory mechanisms (Blois et al., 2007).  
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Findings of the current study coincide with previous research as we also found an 
increase in the gene expression of CD11c, FOXP3, IL-2RA, and IL-10 with the treatment of 
LGALS1. This suggests that bovine conceptus-derived LGALS1 may have important functions 
in the regulation of the maternal immune environment prior to implantation possibly through 
bovine endometrial Treg activity.  
Nuclear factor kappa B (NFKB) is a transcription factor known to be involved in cellular 
signaling, it is activated by IL-1B. In turn, NFKB can increase expression of IL-1B in an auto 
feedback loop (Mathew et al., 2015). It has been suggested that IL-1 is increased by progesterone 
and estrogen at implantation, and that it maintains a delicate and complex balance that exists 
during the establishment of pregnancy (Martal et al., 1997). In ruminants IL-1B, an adhesion 
molecule in the IL-1 family, is produced by the embryo, trophoblast and endometrium 
(Mathialagan et al., 1992). IL-1 has been shown to increase LIF and IL-6 production in 
endometrial epithelial cells (Laird et al., 2000). The pro-inflammatory cytokines IL-6 and LIF 
have been found to be important for implantation and conceptus viability, in sheep, humans, 
rodents, and pigs (Ashley et al., 2011, Fry et al., 1992, Mathew et al., 2016, Laird et al., 2000). 
The promoter regions of LIF and IL-6 genes contain NFKB binding sites and expression of these 
cytokines in other cells has been shown to be controlled by NFKB (Van der Burg and Van der 
Saag, 1996).  
Importance of LIF in the endometrium was discovered in studies conducted with LIF 
knock-out mice in which implantation did not occur (Stewart et al., 1992). In human 
endometrium, LIF concentrations peak around the time of implantation and, are decreased in 
women with unexplained infertility (Laird et al., 1997).  Studies have shown habitual abortion in 
women can be associated with a decrease in expression of IL-1B and IL-6 (Wolff et al., 2000). 
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LIF was increased in pregnant bovine endometrium compared to cyclic endometrium until day 
13 of gestation where it then remained constant (Oliveira et al., 2017). IL-6 is produced by the 
bovine trophoblast as well as in mice, pigs, and sheep (Mathialagan et al., 1992). IL-6 increases 
the production of complement inhibitors and proteases which may play a role in chorionic 
placentation (Martal et al., 1997). It also increases the permeability of endothelial cells, 
suggesting it may play a similar role in ability of the trophoblast to implant during early 
pregnancy (Maruo et al., 1992).  
Based on findings in Chapter IV, expression of these cytokines may be along the bovine 
uterine surface epithelium to promote enhanced conceptus quality and attachment. The majority 
of immune cells can be found in the underlying stroma which may be the source of LGALS1 
induced regulation of T-cell markers FOXP3 and IL-2RA and anti-inflammatory markers IL-10 
and tolerogenic dendritic cells CD11c. 
The relevance of this study applies to the cattle industry and can be used to further 
advance the knowledge of the immune environment within bovine endometrium before 
implantation of the bovine conceptus. Blois et al. (2007) found that LGALS1 was able to rescue 
pregnancies in rodents at risk of pregnancy failure. This could be caused by inducing a balance 
of pro-inflammatory state in the uterine surface epithelium while an anti-inflammatory state, 
promoted by uterine immune cells in the sub-epithelial tissue. Further research is needed to 
identify which cell types are involved in the expression of pro- vs. anti-inflammatory genes.  
CONCLUSION 
In conclusion, this study identified LGALS1 responsive genes in bovine intercaruncular 
endometrium related to anti-inflammatory and pro-inflammatory states. Here, LGALS1 could 
32 
 
play a role in modulating the maternal immune environment within the endometrium during 
conceptus implantation by inducing cell type-specific expression of pro- and anti-inflammatory 





Gene Primer Primer Sequence (5’-3’) Product 
Size (bp) 
Amp. E. Source of Primer 
NM_174301.3 CXCR4 Forward AAGGCTCAGAAGCGCAAG 102 102.2% (Weiner et al., 2012) 
  Reverse GAGTCGATGCTGATCCCAAT    
NM_015459645.2 MST1R Forward GAAAAGGGCGTAGAGCACTG 195 107.2% Primer3Plus 
  Reverse CAACAGCCCGTTGAATAGGT    
NM_001191189.1 TNFAIP2 Forward GCCTTTGATGGATTTCTGGA 239 103.6% Primer3Plus 
  Reverse CTGCGTGAACCTCTTGAACA    
NM_001243311.1 OTUD4 Forward AGCCTTTACCAGGACCCACT 242 111.3% Primer3Plus 
  Reverse GGGACCTTTGGGTACATCCT    
NM_025000176.1 ATP11A Forward GGTGATGGTGCTCACAGTCA 133 98.6% Primer3Plus 
  Reverse CCAGATGACTCCTCCCCAGA    
NM_001102526.1 PROSER2 Forward CCTTGAACGCAAGAAAGAGG 197 95.5% Primer3Plus 
  Reverse GGGAAGTGGACCTCAAAACA    
XM_002699238.6 SLC15A3 Forward GGTGGCCTTTATCCAACAGA 174 103.8% Primer3Plus 
  Reverse GGACAGCAGTTTTGGAGAGC    
XM_024986067.1 CHST15 Forward TCTGCTCTCTTGTGTGCGAG 119 97.1% Primer3Plus 
  Reverse CCTGGGTAGTGAGAGAGGCT    
NM_174358.2 IL-2RA Forward ACATCGGCAGTGGTCTCAG 59 109.1% (Zoldan et al., 2014) 
  Reverse GAACCTCCACATCAGCAAGC    
XM_024985296.1 CD11C Forward CCCCAAATAAGAACCCCACC 71 101.1% (Mathew et al., 2018) 
  Reverse ACCCAGATACGAGTCCCTCA    
NM_001045933.1 FOXP3 Forward TGGTGCTGGAGAAGGAGAAG 92 100.6% (Mathew et al., 2018) 
  Reverse GTCAGATGATGCCGCAGATG    
NM_174088.1 IL-10 Forward CCAAGCCTTGTCGGAAATGA 91 99.7% (Fonseca et al., 2009) 
  Reverse GTTCACGTGCTCCTTGATGTCA    
NM_173923.2 IL-6 Forward CGCATGGTCGACAAAATCTCT 69 95.3% (Mathew et al., 2019) 
  Reverse GCTGCTTTCACACTCATCATTCTT    
NM_001076409.1 NFKB1 Forward ATACTGAACAATGCCTTCCGG 135 96.0% (Meade et al., 2008) 
  Reverse CACGTCAATGGCCTCAGTGTAG    
NM_174093.1 IL-1B Forward ACCTGAACCCATCAACGAAATG 74 93.0% (Mathew et al., 2019) 
  Reverse TAGGGCCATCAGCCTCAAATAACA    
NM_173931.1 LIF Forward GGGACAACTCAACAGCAGTG 91 96.0% Primer3Plus 
  Reverse GCACAGCTTGTCCAGGTTG    
NM_001075297.1 IL-33 Forward TTGTTTTGGAGGATGGAAGC 163 97.8% (Killeen et al., 2014) 
  Reverse TTTGTGGGCTCAGGTTTAC    
NM_174355.2 IL-12a Forward GAATGCAAAGCTTCTGATGGA 111 92.4% Primer3Plus 
  Reverse GGCACAGTCTCACTGTCGAA    
NM_174368.3 ITGB1 Forward TCAGACTTCCGAATTGGGTTTG 118 97.5% (Oliveira et al., 2017) 
  Reverse AAATGGGCTCGTGCAGTTCT    
NM_001014389.2 H3F3A Forward CATGGCTCGTACAAAGCAGA 136 -  
  Reverse ACCAGGCCTGTAACGATGAG    
NM_174178.2 SDHA Forward ACTTCACCGTTGATGGCAA 59 -  
  Reverse GCAGAAATCGCATCTGAAA    
       
 
 
Table 3.1- GenBank accession number, gene name, primer sequence (forward and reverse), 





Figure 3.1 Least squares means relative expression values for FOXP3 in endometrial 
explants (n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 
100, or 1000 ng/mL). There was a significant effect of treatment (Contrast; P < 0.05) 
when all LGALS1 treatments were compared to Control. (SEM= 0.23). 
* 
SEM = 0.23 
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Figure 3.2 Least squares means relative expression values for IL-10 in endometrial explants 
(n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 
1000 ng/mL). There was a significant effect of treatment (Contrast; P < 0.01) when 
all LGALS1 treatments were compared to control. At 6 h (SEM=0.14) at 24 h 
(SEM= 0.41). 
** ** 
SEM = 0.41 














Figure 3.3 Least squares means relative expression values for IL-2RA in endometrial explants 
(n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 
1000 ng/mL). There was a significant effect of treatment (Contrast; P < 0.05) when all 
LGALS1 treatments were compared to Control. (SEM= 0.33). 








Figure 3.4 Least squares means relative expression values for CD11c in endometrial explants 
(n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 
1000 ng/mL). There was a tendency for an effect of treatment (Contrast; P = 0.06) 
when all LGALS1 treatments were compared to Control. (SEM; 0.17). 
P= 0.06 SEM = 0.17 
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Figure 3.5 Least squares means relative expression values for IL-1B in endometrial explants 
(n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 
1000 ng/mL). There was a significant effect of treatment (Contrast; P < 0.001) when 
all LGALS1 treatments were compared to Control. At 6 h (SEM= 0.31) at 24 h 
(SEM= 0.43). 
*** *** SEM = 0.43 












Figure 3.6 Least squares means relative expression values for LIF in endometrial explants 
(n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 
1000 ng/mL). There was a significant effect of treatment at 6 h (Contrast; P < 0.001) 
and at 24 h (Contrast; P < 0.01) when all LGALS1 treatments were compared to 
Control. At 6 h (SEM= 0.17) at 24 h (SEM= 0.28). 













Figure 3.7 Least squares means relative expression values for IL-6 in endometrial explants 
(n=4 uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 
1000 ng/mL). There was a significant effect of treatment (Contrast; P < 0.001) when 
all LGALS1 treatments were compared to Control. At 6 h (SEM= 1.09) at 24 h 
(SEM= 0.19). 
SEM = 1.09 














Figure 3.8 Least squares means relative expression values for CXCR4 in endometrial explants (n=4 
uteri) treated with increasing concentrations of LGALS1 (Control, 10, 100, or 1000 ng/mL). 
There was a significant effect of treatment (Contrast; P < 0.05) when all LGALS1 treatments 
were compared to Control. (SEM= 0.52). 





  Treatment   Contrast 
Gene Time Control 10 100 1000 SEM TRT C 
ATP11a 6 1.13 1.12 0.87 1.24 0.21 NS NS 
 24 0.70 1.00 0.70 1.05 0.16 NS NS 
 6+24 0.92 1.06 0.79 1.14 0.13 NS NS 
CHST15 6 0.51 0.53 0.48 0.50 0.13 NS NS 
 24 2.15 2.45 2.40 2.56 0.44 NS NS 
 6+24 1.70 2.13 2.39 2.26 0.47 NS NS 
EIF4EBP2 6 1.25 1.02 1.00 0.79 0.21 NS NS 
 24 1.04 1.28 0.91 1.00 0.27 NS NS 
 6+24 1.15 1.15 0.95 0.89 0.18 NS NS 
FSD1 6 0.93 0.92 1.14 0.98 0.25 NS NS 
 24 0.89 1.17 1.18 1.41 0.28 NS NS 
 6+24 0.91 1.04 1.16 1.19 0.19 NS NS 
FNDC3B 6 0.98 0.99 1.06 1.16 0.21 NS NS 
 24 0.91 1.23 1.09 0.92 0.09 NS NS 
 6+24 0.95 1.11 1.07 1.04 0.13 NS NS 
IL-34 6 0.98 0.85 1.28 1.17 0.22 NS NS 
 24 1.79 1.47 0.99 0.87 0.59 NS NS 
 6+24 1.38 1.16 1.34 1.02 0.31 NS NS 
ITGB1 6 0.82 0.87 0.87 0.79 0.07 NS NS 
 24 1.10 1.37 1.31 1.27 0.20 NS NS 
 6+24 0.96 1.12 1.09 1.03 0.18 NS NS 
LGALS1 6 0.78 1.00 1.24 1.02 0.21 NS NS 
 24 1.13 1.61 1.46 0.96 0.46 NS NS 
 6+24 0.96 1.30 1.35 0.99 0.30 NS NS 
LGALS9 6 0.82 0.84 0.73 0.80 0.82 NS NS 
 24 1.23 1.32 1.99 1.25 0.12 NS NS 
 6+24 1.02 1.08 1.06 1.02 0.16 NS NS 
MST1R 6 0.73a 0.49a 1.18ab 1.33ac 0.37 < 0.01 NS 
 24 1.19 1.56 1.68 2.40 0.78 NS NS 
 6+24 0.96 1.02 1.43 1.86 0.23 NS NS 
SLC15A3 6 0.87 0.94 1.39 1.40 0.37 NS NS 
 24 1.03 0.99 1.20 1.13 0.33 NS NS 
 6+24 0.95 0.96 1.30 1.27 0.24 NS NS 
Table 3.2 Summary of relative expression data for genes amplified by RT-qPCR in endometrial explants treated 
with increasing concentrations of LGALS1. LSM + SEM. P-values are that of the log-transformed data. 






  Treatment   Contrast 
Gene Time Control 10 100 1000 SEM TRT C 
FOXP3 6 1.74 1.58 1.76 1.81 0.30 NS NS 
 24 0.57 0.75 0.78 0.75 0.23 NS < 0.05 
 6+24 1.16 1.16 1.27 1.28 0.31 NS NS 
IL2-RA 6 1.13a 1.08a 2.19ab 3.11bc 0.67 < 0.01 0.06 
 24 0.54a 0.65a 1.00a 1.26b 0.33 < 0.05 < 0.05 
 6+24 0.84a 0.86a 1.59ac 2.19bc 0.51 < 0.01 0.07 
CD11c 6 1.24 0.89 1.43 1.59 0.60 NS NS 
 24 0.76 0.91 1.21 1.37 0.17 0.10 0.06 
 6+24 1.00 0.90 1.32 1.48 0.34 NS NS 
IL-10 6 1.15a 1.94a 2.21b 2.76bc 0.41 < 0.01 < 0.01 
 24 0.52a 0.52ab 0.70ac 0.91c 0.14 < 0.001 < 0.01 
 6+24 0.83 0.96 1.45 1.83 0.34 NS NS 
Table 3.3 Summary of relative expression data for Treg and anti-inflammatory related 
genes amplified by RT-qPCR in endometrial explants treated with increasing 
concentrations of LGALS1. LSM + SEM. P-values are that of the log-transformed 
data. Contrast: Control vs. Galectin-1 (10, 100 and 1000ng/mL). 
44 
 
  Treatment   Contrast 
Gene Time Control 10 100 1000 SEM TRT C 
CXCR4 6 0.31 0.27 0.27 0.31 0.07 NS NS 
 24 3.10 3.99 4.50 4.20 0.52 NS < 0.05 
 6+24 1.70 2.13 2.39 2.26 0.74 NS NS 
LIF 6 0.44a 0.65b 1.10c 1.91d 0.17 < 0.001 < 0.001 
 24 0.65 1.20 1.43 2.13 0.28 < 0.05 < 0.01 
 6+24 0.54a 0.93b 1.26bc 2.02d 0.17 < 0.001 < 0.001 
IL-33 6 1.25a 1.32a 1.27a 1.67b 0.33 NS NS 
 24 0.87 1.08 1.14 0.76 0.24 NS NS 
 6+24 1.06 1.20 1.21 1.21 0.22 NS NS 
IL-1B 6 0.33a 0.70b 1.35bc 2.54c 0.31 < 0.001 < 0.001 
 24 0.49a 1.24b 2.90b 2.65b 0.43 < 0.01 < 0.001 
 6+24 0.41a 0.97b 2.12cd 2.59d 0.33 < 0.001 < 0.001 
IL-6 6 0.34a 1.12b 4.07c 6.98cd 1.09 < 0.001 < 0.001 
 24 0.23a 0.61b 1.10bc 1.77cd 0.19 < 0.001 < 0.001 
 6+24 0.29a 0.86b 2.59c 4.38d 0.76 < 0.001 < 0.001 
TNFAIP2 6 1.52a 1.34a 3.80ac 8.29b 1.80 < 0.01 < 0.05 
 24 0.47 0.49 0.42 0.49 0.12 NS NS 
 6+24 1.00 0.91 2.11 4.39 1.16 NS NS 
IL-12a 6 1.31 1.18 1.55 1.78 0.46 NS NS 
 24 1.13 0.88 0.87 0.77 0.26 NS NS 
 6+24 1.22 1.03 1.21 1.27 0.27 NS NS 
NFKB1 6 0.67a 0.88a 1.48bc 1.86c 0.23 < 0.001 < 0.001 
 24 0.75a 0.85a 1.12a 1.31b 0.18 < 0.05 < 0.05 
 6+24 0.71a 0.86ab 1.30b 1.58bc 0.16 < 0.001 < 0.01 
Table 3.4 Summary of relative expression data for pro-inflammatory related genes amplified by 
RT-qPCR in endometrial explants treated with increasing concentrations of LGALS1. 
LSM + SEM. P-values are that of the log-transformed data. Contrast: Control vs. 





EFFECT OF GALECTIN-1 ON BOVINE ENDOMETRIAL EPITHELIAL AND 
FIBROBLAST CELLS IN 3-DEMENTIONAL CELL CULTURE  
 
Abstract 
 Galectin-1 plays an important role during reproduction in humans and rodents. Galectin-1 
is expressed by the early bovine conceptus. This study investigated the effects of LGALS1 on 
bovine endometrial epithelial and fibroblast cell (n=4) transcriptomes in a 3-D-culture system 
treated with media only (Control) or media containing 10 or 100 ng/mL of bovine LGALS1 for 6 
h. Transcriptomes of Control cells and cells treated with 100 ng/mL of bovine LGALS1 were 
assayed by RNA Sequencing. Transcriptomes of Control cells and cells treated with 10 and 100 
ng/mL of bovine LGALS1 were assayed by RT-qPCR. In epithelial cells treated with LGALS1 
there were 1260 up-regulated genes. The top ten up-regulated genes were IL-1B, FGR, BATF2, 
STEAP4, SAA, CCL20, CXCL10, IL36A, S100A9, and M-SAA3.2. There were 2021 down-
regulated genes in epithelial cells. The top ten were MSRB1, MSD2, USP6NL, SRF, STARD7, 
RARA, PIAS2, CDC42EP3, MRPL36, and PDLIM5. In fibroblast cells treated with LGALS1 
there were seven up-regulated genes and no down-regulated genes. The up-regulated genes were 
of OAS1Y, OAS1X, OAS1Z, ISG15, LOC112441507, BMST2, and IRF9. Other genes of interest, 
LIF and CXCR4 were investigated because of their well-known role in reproduction and up-
regulation by LGALS1. Gene ontology (GO) showed that up-regulated genes contributed to 
pathways involved in many immune and inflammatory pathways. This study provides evidence 
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that bovine LGALS1 affects bovine endometrial epithelial and fibroblast cells gene expression. 
Considering, LGALS1 is expressed by the early bovine conceptus, conceptus LGALS1 may 
modulate endometrial cell gene expression during early gestation. The LGALS1 may increase 
expression of inflammatory type genes at the uterine surface.  
INTRODUCTION 
Most researchers use a 2-dimensional (D) monoculture system to study endometrial 
epithelial cell function in vitro. However, the development of a 3-D culture system used in this 
study provides a more realistic reflection of the tissue functions and 3-D architecture of the 
tissue. This system allows cells of different types to be co-cultured in an arrangement similar to 
in vivo tissue allowing for cell to cell communication and measurement of apical and basolateral 
protein secretions. Further, cells can be easily collected after the co-culture for mRNA and 
protein analysis (MacKintosh et al., 2015).  
In a study conducted on mice with colitis, endogenous LGALS1 was highly expressed in 
the epithelial cells in the colon of unaffected mice while markedly reduced in the colon of mice 
with colitis. The mice with colitis had epithelial architecture damage; however, with treatment of 
LGALS1, the epithelial layer architecture was almost completely restored. In this study, 
LGALS1 was also found to regulate the immune system by creating and maintaining tolerance 
by causing selective apoptosis of activated mature lymphocytes to maintain immune homeostasis 
(Santucci et al., 2003). 
Previous research has shown that LGALS1 is important for the maintenance of a 
successful pregnancy in humans and rodents; however, its importance in bovine pregnancy has 
not been well characterized. In a previous study, LGALS1 reduced fetal loss in sound stressed 
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rodents. Investigators discovered that LGALS1 increased the presence of regulatory T- cells 
(Treg) in the uterus, thus promoting fetomaternal tolerance. In cases where the presence of Treg 
was reduced, the effects were lost and there was a higher percentage of fetal loss. Through these 
findings, the investigator concluded that LGALS1 plays a pivotal role in the fetomaternal 
tolerance through modulation of immunoregulatory mechanisms (Blois et al., 2007). There is 
limited research on the role of LGALS1 in cattle but studies have identified the presence of 
LGALS1 in the conceptus as well as caruncular and intercaruncular regions of pregnant bovine 
endometrium, specifically the maternal stroma, at all stages of gestation (Froehlich et al., 2012). 
Through RNA- Sequencing (RNA-Seq), LGALS1 was found to be expressed by the pregnant 
endometrium and early bovine conceptus as early as day 16 of gestation (Mansouri-Attia et al., 
2009, Mamo et al., 2012, Forde et al., 2015). Studies have shown reduced LGALS1 expression 
in vitro produced blastocysts compared to in vivo produced bovine blastocysts, which could be 
cause for high embryonic loss and poor pregnancy rates following transfer of an in vitro 
produced blastocyst (Mohan et al., 2004).  Galectin-1 relative mRNA expression was also 
reduced in the endometrium of low fertility dairy heifers and was found to be involved in cellular 
growth and proliferation, cell morphology, small molecule biochemistry, and lipid metabolism 
through IPA analysis. These mechanisms could be contributing to the endometrial facilitated 
infertility in cattle, thus showing the importance of LGALS1 in the species (Killeen et al., 2014). 
Considering that the bovine conceptus is hypothesized to secrete LGALS1 onto the uterine 
surface, we investigated the effect of LGALS1 on the bovine endometrial epithelium and 
fibroblast transcriptomes during 3-D culture. 
MATERIALS AND METHODS 
Cell Collection, Isolation, and Culture 
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Bovine uteri (n=4) were collected at a local slaughter facility and endometrium was 
collected  from mid-luteal phase uteri; ipsilateral to the corpus luteum (CL) (Cronin et al., 2014). 
Briefly, uteri were transported on ice to the laboratory where they were washed with 1X 
Dulbecco’s Phosphate-Buffered Saline (DPBS; Gibco, Gaithersburg, MD) containing 1% 
antibiotic-antimycotic (ABAM; ThermoFisher Scientific, Waltham, MA). The broad ligament 
was removed, and the uterine horn ipsilateral to the CL was dissected free from the reproductive 
tract. The uterine horn was washed again with 1X DPBS (1% ABAM) and sprayed with 70% 
EtOH. Under sterile procedures the uterine horn was dissected longitudinally to obtain 
intercaruncular endometrial strips which were washed in a series of 3 washes of Hank’s 
Balanced Salt Solution (HBSS; Gibco), the last containing 1% ABAM. Before the last HBSS 
wash, endometrial strips were cut into approximately 3 mm pieces. The endometrium in HBSS 
was then incubated at 38.8°C with 5% CO2 for 10 min. Tissue was then transferred into a 
digestive solution containing HBSS, 100X Trypsin-EDTA (7%, Sigma Aldrich, St. Louis, MO), 
collagenase II (25 mg; Sigma Aldrich), DNase 1 (125 μL; Sigma Aldrich), and bovine serum 
albumin (50 mg BSA; Sigma Aldrich), and incubated for 1 hour in a 38.8°C water bath with 
manual agitation every 10 min. Digested tissue was filtered through a 100 μM over a 40 μM cell 
strainer (Falcon, Corning, NY) into 5 mL of pre-warmed HBSS and 10% fetal bovine serum ( 
FBS; Sigma Aldrich). Epithelial cells were collected by back washing the 40 uM cell strainer 
with 30 mL of Rosewell Park Memorial Institute (RPMI) medium (Gibco) containing 10% FBS 
and 1% ABAM (Complete media). Fibroblast cells were collected in the filtered flow-through 
media. Cells were plated into T75 flasks (CELLSTAR, Monroe, NC) and incubated at 38.8°C in 
5.0% CO2 and atmospheric oxygen. Media on epithelial cells was changed every two days and 
every other day for fibroblast cells. When cells became 80% confluent they were detached using 
49 
 
Accutase cell detachment solution (Sigma Aldrich) and passed into three new T75 flasks in 
complete media.  
In preparation for 3-D culture and once epithelial cells were 95-100% confluent, they 
were detached using Accutase and plated into hanging cell culture inserts (Millipore Sigma) 
coated with a thin coat of Matrigel Matrix (1:8; Matrigel: RPMI; Corning Incorporation, 
Corning, NY) at a concentration of 3 X 105 cells/mL. Inserts were placed into wells of 24 well 
plates (CELLSTAR) containing 800 μl of complete media. Media was replaced every two days. 
Transepithelial electrical resistance (TEER > 1500 Ωcm2) was met after 8 days and fibroblasts 
were then prepared for 3-D culture. Fibroblast cells were plated into 24 well plates at 1 X 
105 cell/mL. After 18 h, and on day of treatment, the fibroblast media was replaced with RPMI 
containing 5% FBS and 1% ABAM (treatment media) the media of epithelial cells in transwell 
inserts was also replaced with treatment media, and the inserts were added to the 24 well plates 
with fibroblasts. After 2 h, epithelial cell media was removed and replaced with 300 μl of 
treatment media (Control), or treatment media containing 10 or 100 ng/mL of recombinant 
bovine (Cusabio, Houston, TX) for 6 h. Four uteri were used to prepare four different 3-D 
cultures and cell treatments were applied in triplicate for each uterus. The FBS included in the 
treatment media for each uterus was from a single aliquot.  
RNA Extraction 
Following treatment, epithelial cells were collected by removing the transwell membrane 
and placing it in the Qiagen RNeasy Kit (Qiagen, Hilden, Germany) lysis buffer. The lysis buffer 
was also added to fibroblast cells which were then scraped off the bottom of the 24 well plates. 
Briefly, total RNA was extracted from fibroblast and epithelial cells separately following the 
Qiagen RNeasy Kit instructions. The quantity of isolated RNA for each cell type was determined 
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using the NanoDrop 1000 (Thermo Fisher Scientific, Waltham, MA) and quality was assessed 
using Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). The RNA integrity 
number (RIN) was between 7 and 10 for all samples. For each uteri 3-D cell culture, triplicate 
epithelial cell and fibroblast cell RNA for each treatment were pooled furing RNA isolation and 
prior to cDNA synthesis.  
RNA-Sequencing 
The RNA samples from endometrial fibroblast and epithelial cells treated with 100 
ng/mL of recombinant bovine LGALS1 were submitted for RNA sequencing. RNA library 
preparation and sequencing was conducted by the University of Missouri DNA Core facility as 
described by (Moraes et al., 2018). The raw sequences (fastq) underwent adapter removal and 
quality trimming utilizing Trimmomatic (Bolger et al., 2014). The quality reads were then 
mapped to the bovine reference genome ARS-UCD1.2 using Hisat2 mapper, a sensitive and fast 
alignment program of next-generation sequencing data (Kim et al., 2015). The sorted binary 
alignment maps and the NCBI gene annotation of the ARS-UCD1.2 assembly were subjected to 
FeatureCounts to quantify read counts of genes for each sample (Liao et al., 2014). Differential 
gene expression analysis between sample groups was performed by robustly fitting the 
expression data to a weighted generalized linear model (GLM) using edgeR robust (Zhou et al., 
2014). The DAVID Bioinformatics Resource 6.8 was used to carry out a GO analysis of 
transcripts found to be statistically significant during the RNA-Seq analysis (Huang da et al., 
2009). An enriched biological process (BP) and Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathway analyses were included. The GO Direct category was used during the 
annotation and provides mappings directly annotated by the source database. The Homo sapien 
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background was used during the analysis, and GO Direct and KEGG categories were considered 
enriched when P ≤ 0.05 with Benjamini-Hochberg procedure. 
RT-qPCR 
Explant mRNA (500ng) was reverse transcribed into cDNA using the High-capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA), and cDNA samples 
were diluted 1:20 in nuclease free water. Reactions were 20 μL including 10 μL of PowerUP 
SYBR Green Master Mix (Bio-Rad; Hercules, CA), 1.2 μL of each primer, and 2.6 μL of DNase 
RNase free water, and 5 μL of sample following the manufacturer’s instructions. No reverse 
transcriptase controls were included for a subset of samples. The RT-qPCR reactions were 
carried out using PowerUp SYBR Green Master Mix (Applied Biosystems) and the CFX96 
Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA) following the manufacturer’s 
recommendations. All samples were ran in duplicate and no reverse transcriptase controls and no 
template controls were included. Primers were created using Primer3Plus or obtained from 
previously published research. The PCR primer amplification efficiencies (E) for each PCR 
target sequence were calculated from the standard curve generated from seven cDNA dilutions 
made from a pool of cDNA samples. Diluted in a buffer containing 1% 100X Tris EDTA (Sigma 
Aldrich) 0.4% lambda DNA (Invitrogen, Carlsbad, CA) and DNase and RNase free water. 
Dilutions were 1:1, 1:4, 1:16, 1:64, 1:256, 1:1024, 1:4096, respectively. The equation used for 
the efficiency calculation was E = [10(-1/slope) -1]. Slope generated from plotting Ct values against 
dilution for each serial dilution. Percent primer efficiency was calculated by dividing E by 2 and 
then multiplying by 100. Only primers with efficiencies between 90-110% were used. A 
dissociation analysis was included for each primer pair to evaluate primer specificity for the 
target sequence. Gel electrophoresis was used to confirm the primer pair by amplicon size.  
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Qbase+ qPCR analysis software (Biogazelle, Zwijnaarde, Belgium) was used to calculate 
the normalized relative expression quantities (NRQ; relative expression) of target genes based on 
a generalized delta-delta quantification cycle method (ΔΔCq; also known as ΔΔCT) (Hellemans 
et al., 2007). To identify potential normalization targets, RT-qPCR was carried out for eight 
potential genes across a subset of samples representing all treatments. Genes tyrosine 3-
monooxygenase/ tryptophan 5-monooxygenase activation protein zeta (YWHAZ) and peptidyl-
prolyl isomerase A (PPIA) were found to be the most stably expressed across treatments using 
the geNorm analysis (geNorm M < 0.25) (Vandesompele et al., 2002). The RT-qPCR thermo 
cycler settings for all reactions consisted of an initial temperature of 50°C for 2 min, 95°C for 2 
min followed by 40 PCR cycles consisting of melting at 95°C for 15 sec and annealing and 
extension at 60°C for 1 min.  
Statistical Analysis  
A mixed procedure (proc MIXED) in the statistical analysis software (SAS) was used to 
analyze the RT-qPCR relative expression data. The statistical analysis tested the effect of 
treatment on relative gene expression for selected genes of interest. All treatments were applied 
to each uterus, therefore, uterus was considered a block and specified as a random variable in the 
model.  Data residuals were scrutinized for normality using the PLOTS=(diagnostics residuals) 
statement. All p-values for gene expression data presented are that of a log base-10 (log10) 
correction. If the residuals were not normal after log10 transformation, the residual data were 
normalized using square root (sqrt) transformation. All relative expression values are presented 
in their original format; however, the p-values are of the log10 or sqrt transformed data. Three 
treatments were included in the analysis including Control, 10, or 100 ng/mL of recombinant 
bovine LGALS1. One orthogonal contrast statement was included, Contrast 1 (C1), comparing 
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the media only treatment (Control) vs. both LGALS1 treatments (10 and 100 ng/mL). Data are 
presented as least squares means (LSM) ± standard error of the least squares means (SEM). 
Statistical significance was declared at a P ≤ 0.05. 
RESULTS 
Up-regulated Genes in Epithelial Cells 
Compared to controls, epithelial cells treated with 100ng/mL of LGALS1 had 1260 up-
regulated genes. The ten most up-regulated genes were; 1) Interleukin-1 beta (IL-1B), 2) FGR 
proto- oncogene, Src family tyrosine kinase (FGR), 3) basic leucine zipper transcriptional factor 
ATF-like 2 (BATF2), 4) STEAP4 metalloreductase (STEAP4) 5) serum amyloid A protein (SAA), 
6) C-C motif chemokine ligand 20 (CCL20),7) C-X-C chemokine ligand 10 (CXCL10), 8) IL-
36A, 9) S100 calcium binding protein A9 (S100A9), and 10) mammary serum amyloid A3.2 (M-
SAA3.2). 
 Gene ontology analysis of the 1260 up-regulated genes in response to 100 ng/mL of 
LGALS1 identified 64 enriched pathways (Table 4.1). The ten most enriched pathways were 1) 
inflammatory response, 2) positive regulation of NFKB transcription factor activity, 3) type-1 
interferon signaling pathway, 4) apoptotic process, 5)innate immune response, 6) Interferon 
(IFN)-γ mediated signaling pathway, 7) immune response, 8) defense response to virus, 9) 
response to virus, and 10) response to lipopolysaccharide (LPS). The KEGG pathway analysis 
identified 35 enriched pathways in epithelial cells treated with 100 ng/mL of LGALS1 (Table 
4.3). The top ten most enriched KEGG pathways were 1) tumor necrosis factor (TNF) signaling 
pathway, 2) influenza A, 3) nuclear factor kappa B (NFKB) signaling pathway, 4) C-X-C 
chemokine receptor (CXCR) interaction, 5) herpes simplex infection, 6) measles, 7) NOD-like 
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receptor signaling pathway, 8) pertussis, 9) Retinoic acid-inducible gene-1 (RIG-I) -like receptor 
signaling pathway, and 10) toll-like receptor (TLR) signaling pathway. 
Down-regulated Genes in Epithelial Cells 
Compared to controls, epithelial cells treated with 100 ng/mL of LGALS1, there were 
2921 down-regulated genes. The 10 most up-regulated genes were; 1) methionine sulfoxide 
reductase B1 (MSRB1), 2) nuclear receptor binding SET domain protein 2 (MSD2), 3) USP6 N-
terminal like (USP6NL), 4) serum response factor (SRF), 5) StAR related lipid transfer domain 
containing 7 (STARD7), 6) retinoic acid receptor alpha (RARA), 7) protein inhibitor of activated 
STAT2 (PIAS2), 8) CDC42 effector protein 3 (CDC42EP3), 9) mitochondrial ribosomal protein 
L36 (MRPL36), and 10) PDZ and LIM domain 5 (PDLIM5).   
Gene ontology analysis of the 2921 down-regulated genes in response to 100 ng/mL of 
LGALS1 identified 9 enriched pathways (Table 4.2). The 9 enriched pathways were 1) DNA 
replication, 2) G1/S transition of mitotic cell cycle, 3) DNA replication initiation, 4) DNA strand 
elongation involved in DNA replication, 5) telomere maintenance via recombination, 6) positive 
regulation of transcription from RNA polymerase II promoter, 7) cell division, 8) regulation of 
transcription involved in G1/S transition of mitotic cell cycle, and 9) positive regulation of 
peptidyl-threonine phosphorylation. When subjected to KEGG Pathway analysis, there were 5 
down-regulated pathways in epithelial cells treated with 100 ng/mL of LGALS1 (Table 4.4). The 
5 down-regulated pathways were 1) DNA replication, 2) cell cycle, 3) pathways in cancer, 4) 
signaling pathways regulating pluripotency of stem cells, and 5) human T-cell leukemia virus 
type-1 (HTLV-I) infection.   
Up-regulated Genes in Fibroblasts 
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The treatment of epithelial cells in transwell inserts over fibroblasts were treated with 
100ng/mL of recombinant bovine LGALS1, resulted in up-regulation of 7 genes in the 
fibroblasts. There were no down-regulated genes in the fibroblasts compared to Control. Up-
regulated fibroblast genes included 1) 2’, 5’- oligoadenylate synthetase 1Y (OAS1Y), 2) OAS1X, 
3) OAS1Z, 4) IFN stimulated gene 15 (ISG15), 5) bone marrow stromal antigen 2-like 
(LOC112441507), 6) bone marrow stromal antigen 2 (BMST2), and 7) interferon regulatory 
factor 9 (IRF9). 
Reference Appendix B for additional significant (P < 0.05) KEGG and GO Direct 
pathways with Benjamini-Hochberg procedure. Particular genes of interest that were either up- 
or down-regulated in the RNA Seq results were validated using RT-qPCR. 
RT-qPCR 
 There was an effect of treatment on relative gene expression of CXCR4 in the epithelial 
cells. Expression of CXCR4 mRNA was greater when both LGALS1 treatments were compared 
to Control (Figure 4.2; Control, 10, 100 ng/mL respectively; 6.12, 6.15, 13.77 + 0.89; P < 0.05). 
There was no effect of treatment on relative expression of fibroblast cell CXCR4 mRNA. There 
was an effect of treatment on relative gene expression of EIF4EP2 on epithelial and fibroblast 
cells. Expression of EIF4EBP2 mRNA in epithelial cells decreased when both LGALS1 
treatments were compared to Control (Figure 4.3; 2.43, 0.93, 1.04 + 0.18; P < 0.001). Expression 
of EIF4EBP2 mRNA on fibroblast cells was decreased when both LGALS1 treatments were 
compared to Control (Figure 4.3; 2.06, 0.88, 0.83 + 0.17; P < 0.001). There was an effect of 
treatment on relative gene expression of IL-1B in epithelial cells. Expression of IL-1B mRNA 
was greater when both LGALS1 treatments were compared to Control (Figure 4.4; 0.40, 21.41, 
265.44 + 34.95; P < 0.001). There was not an effect of treatment on relative expression of 
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fibroblast cell IL-1B. There was an effect of treatment on relative gene expression of IL-6 in the 
epithelial cells. Expression of IL-6 mRNA was greater when both LGALS1 treatments were 
compared to Control (Figure 4.5; 1.74, 3.18, 4.89 + 1.33; P < 0.01). There was not an effect of 
treatment on relative expression of IL-6 in fibroblast cells. There was an effect of treatment on 
relative expression of LIF in the fibroblast cells. Expression of LIF mRNA was decreased when 
both LGALS1 treatments were compared to control (Figure 4.6; 0.79, 0.48, 0.52 + 0.28; P < 
0.05). There was an effect of treatment on relative expression of LIF at 100 ng but not at 10 ng in 
the epithelial cells. There was an effect of treatment on relative expression of CHST15 in the 
fibroblast cells. Expression of CHST15 mRNA was decreased when both LGALS1 treatments 
were compared to control (Figure 4.7; 3.86, 1.41, 1.16 + 0.89; P < 0.01). There was not an effect 
of treatment on relative expression of CHST15 in epithelial cells. There was an effect of 
treatment on relative expression of MST1R in the fibroblast cells. Expression of MST1R mRNA 
was decreased when both LGALS1 treatments were compared to control (Figure 4.8; 3.79, 2.53, 
2.60 + 0.53; P < 0.01). There was not an effect of treatment on relative expression of MST1R in 
epithelial cells. There was an effect of treatment on relative gene expression of ATP11a in 
epithelial and fibroblast cells. Expression of ATP11a mRNA in epithelial cells was decreased 
when both LGALS1 treatments were compared to Control (Figure 4.9; 8.42, 3.03, 2.66 + 0.68; P 
< 0.001). Expression of ATP11a mRNA in fibroblast cells was decreased when both LGALS1 
treatments were compared to Control (Figure 4.9; 3.40, 1.82, 1.72 + 0.63; P < 0.001). 
DISCUSSION 
Many of the genes up-regulated in the epithelial cells treated with LGALS1 are 
associated with adhesion and immune regulation. One gene in particular, CXCR4, is important 
for implantation in ruminants. The protein CXCR4 is a G-protein coupled chemokine receptor. 
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This protein plays many roles, one being allowing migration of progenitor cells to their 
destination where they will differentiate to become organs and tissues during embryonic 
development. In the innate immune system, phagocytic cells such as neutrophils and 
macrophages express CXCR4 (Domanska et al., 2013). In humans, a previous study presented 
evidence of LGALS1 up-regulating CXCR4 gene expression through nuclear factor kappa B 
(NFKB) in kidney cancer patients, which promoted progression and invasiveness of tumors 
(Huang et al., 2014).  Another study examined first-trimester human trophoblast cells for 
chemokines and chemokine receptors. Their study found evidence that CXCR4 and CXCL12 
were highly expressed in the trophoblast cells and their function may be to stimulate trophoblast 
cell proliferation or differentiation in an autocrine manner, which may play an important role in 
early pregnancy (Wu et al., 2004). In relation to livestock species, a few studies have been 
conducted in sheep with CXCR4 and have determined that CXCR4 mRNA and protein was 
greater on day 15 of pregnancy compared to the estrous cycle and greatest on days 21 and 30 
compared to earlier days. This study provided evidence to conclude that CXCR4/CXCL12 
pathway is activated during implantation and placentation in sheep and is likely playing a role in 
the communication between trophoblast cells and the maternal endometrium (Ashley et al., 
2011). Similar to Huang et al., (2014), we also observed an increase in CXCR4 with LGALS1 
treatment in endometrial epithelial cells. It is possible that the CXCR4/CXCL12 pathway is also 
activated during implantation and placentation of the cow and contributes to communication 
between the conceptus and endometrium similarly to that in sheep. This suggests a role for 
CXCR4 in bovine endometrium and it is possible that conceptus LGALS1 stimulates its 
expression. Interestingly, CXCR4 was specifically down-regulated in explants cultured with IVF 
produced conceptuses (Mathew et al., 2019). It is possible that down-regulation of CXCR4 is 
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attributed to decreased expression of LGALS1 by IVF produced conceptuses as evidence 
suggests that LGALS1 increases CXCR4 (Huang et al., 2014). 
 Another important gene that was shown to be important in the present study was 
leukemia inhibitory factor (LIF). Importance of LIF in the endometrium was discovered in 
studies conducted with LIF knock-out mice in which implantation did not occur (Stewart et al., 
1992). In human endometrium, LIF concentrations peak around the time of implantation 
however, are decreased in women with unexplained infertility (Laird et al., 1997). The promoter 
region of LIF contains NFKB binding sites and expression of these cytokines in other cells has 
been shown to be controlled by NFKB (Van der Burg and Van der Saag, 1996). This gene has 
been shown to be important in numerous human studies for the regulation of multiple processes 
prior to and during implantation such as uterine transformation into a receptive state, 
decidualization, blastocyst growth and development, embryo- endometrial interaction, 
trophoblast invasion, and immune modulation (Shuya et al., 2011). In a study conducted on 
cultured ovine embryos, researchers found that the addition of human LIF (hLIF) to the culture 
medium significantly improved the development of the embryos compared with control embryos 
prior to transfer. Through their research, they concluded that hLIF has potential as an 
embryotrophic or embryo-protective agent (Fry et al., 1992). Studies in cattle have shown LIF is 
increased in pregnant endometrium compared to cyclic endometrium until day 13 of gestation 
where it then remained constant (Oliveira et al., 2017). Interestingly, LIF expression increased in 
response to 100 ng/mL of LGALS1 in epithelial cells but decreased in the fibroblast cells in the 
3-D culture system in response to 10 and 100 ng/mL of LGALS1. It is possible that higher 
concentrations of LGALS1 up-regulates LIF in the uterine epithelium. The LIF gene is 
considered an embryokine, and might promote development and growth of the conceptus. 
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The most highly expressed gene in epithelial cells treated with LGALS1 was the pro-
inflammatory cytokine, IL-1B.  The transcription factor, NFKB is known to be involved in 
cellular signaling from IL-1 in many cell types. It has been suggested that IL-1 secretion is 
stimulated by seminal plasma at the time of fertilization, is increased by progesterone and 
estrogen at implantation, and that it maintains a delicate and complex balance that exists through 
the establishment of pregnancy (Martal et al., 1997). The cytokine, IL-1 has been shown to 
increase LIF production in endometrial epithelial cells (Laird et al., 2000). Studies have shown 
habitual abortion in women can be associated with a decrease in the expression of IL-1B (Wolff 
et al., 2000). In ruminants IL-1B is produced by the conceptus and endometrium (Mathialagan et 
al., 1992). Endometrial epithelial cells treated with LGALS1 had increased expression of IL-1B 
and LIF. It is possible that LGALS1 is causing an increased expression in IL-1B which is then 
causing increased expression of LIF within the endometrial epithelium of cattle similarly to 
previous research.  
 The genes EIF4EBP2, CXCR4, CHST15, MST1R, and ATP11a were of specific interest 
to this study due to their differential expression in a study conducted by (Mathew et al., 2019). 
The genes EIF4EBP2, CHST15, and MST1R have been shown to be involved in tumorigenesis, 
tumor development and progression, and have been found in the epithelial cells of tumors 
(Benight and Waltz, 2012, Ito et al., 2017, Musunuru, 2003). The gene ATP11a has been found 
to have flippase activiy which transports phospholipids across the plasma membrane (Takatsu et 
al., 2014).  In a study conducted by Mathew et al., (2019), endometrial explants were cultured 
with artificial insemination (AI) or in vitro fertilization (IVF) derived conceptuses or in culture 
medium containing interferon-tau (IFNT) in this study. Interestingly, genes CHST15, ATP11a, 
and EIF4EBP2 were down-regulated in endometrial explants treated with AI produced embryos. 
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The genes were found to be independent of IFNT and possibly differentially expressed in 
response to conceptus secretory factors (CSF) (Mathew et al., 2019). We did not observe an 
increase in epithelial or fibroblast cell ATP11a in response to LGALS1. In fact, expression 
decreased in both cell types (10 or 100 ng/mL). It is possible that additional CSF, other than 
LGALS1, also modify expression of ATP11a and are responsible for the increase in expression 
observed in total endometrium treated with conceptuses. It is also possible that there are other 
cells present in explants but not found in 3-D cultures that could also express ATP11a. In this 
study, the genes EIF4EBP2 and CHST15 were down-regulated in fibroblast cells in response to 
10 and 100 ng/mL of LGALS1. In the epithelium, decreased expression may depend on 
concentration of LGALS1 as expression of CHST15 increased in these cells in response to 100 
ng/mL of LGALS1. Expression of both EIF4EBP2 and CHST15 decreased in the epithelium in 
response to 10ng/mL of LGALS1. Overall, it is possible that conceptuses decrease expression of 
EIF4EBP2 and CHST15 in the stroma through secretion of LGALS1. In the same study by 
(Mathew et al., 2019) the genes MST1R, and IL-6 were up-regulated in endometrium treated with 
day 15 conceptuses.  Previous studies have shown an embryokine function of IL-6 in bovine pre-
implantation embryos by enhancing inter-cell mass development in IVP embryos (Wooldridge 
and Ealy, 2019). The data of the current study shows increased relative expression of IL-6 in 
endometrial epithelial cells treated with LGALS1 (10 or 100 ng/mL). Epithelial expression of 
MST1R however, increased in response to 100 but not 10 ng/mL of LGALS1. Due to the 
importance of IL-6 during pregnancy of other species, it is hypothesized that it would be 
important during early pregnancy in cattle. Clearly, expression depends on endometrial cell type 
and concentration of LGALS1. Therefore, it could be concluded that a delicate balance of 




Results of the present study show evidence for a role of LGALS1 during early pregnancy 
in the cow. Galectin-1 might increase endometrial expression of CXCR4 and LIF through 
activation of the NFKB pathway in cattle (Figure 6.1). The CXCR4 and LIF genes are important 
for trophoblast invasion and communication between the conceptus and maternal endometrium. 
Galectin-1 induced up-regulation of pro-inflammatory cytokines IL-1B and IL-6 in bovine 
endometrial epithelial and fibroblast cells suggests that LGALS1 may promote an inflammatory 
like environment along the uterine surface. Pro-inflammatory cytokines are believed to be 
necessary for successful pregnancy, especially at the conceptus-maternal interface (Mathew et al., 
2015). The gene ontology pathways support these data with many of the enriched pathways being 
related to pro-inflammatory cytokines and regulation of the immune system. 
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 Table 4.1- Gene Ontology Biological Process Direct for genes up-regulated in bovine endometrial 
epithelial cells treated with 100ng/mL of bovine LGALS1 in 3-D culture 
    
Up Biological Process P Value Genes 
 
inflammatory response 0.000 
PTGS2, ELF3, S100A8, TBK1, IL19, S100A9, TLR2, TLR3, 
TLR4, NFKB1, NFKB2, TLR6, CXCL10, CCRL2, S1PR3, 
TNFRSF11B, CASP4, CXCR4, LTB4R, MGLL, IL-1B, VNN1, 
FAS, ADAM8, TNIP1, IL1A, CIITA, IRAK2, NFKBIZ, 
PTGER2, C5AR2, SP100, IL18RAP, GBP5, LYN, RELB, 
CHST2, CD40, IFI16, TNFRSF9, TNFAIP6, PTGDR, RIPK2, 
NAIP, TNFAIP3, IL36A, TNFRSF21, CCL2, NMI, TNF, 
CXCL5, C3, ADORA2A, CXCL3, CSF1, C5, CXCL2, CXCL8, 
CCL5, IL34, CCL22, CCL20, ITGB6, ZC3H12A, BLNK, LY75, 
SELP, IL-6, LIPA, CEBPB, OLR1, CHI3L1, SMAD1, 
LGALS9, S100A12, LAT, APOL3, CYBA, CLEC7A, IKBKB, 
CD14, F2R 
positive regulation of NF-kappaB transcription factor activity 0.000 
TRAF1, TNF, S100A8, NFKBIB, S100A9, TLR2, TRIM14, 
NFKBIA, TLR3, NFKB1, TLR4, NFKB2, TNFSF18, IRAK3, 
TRIM5, NOD2, TRIM8, RBCK1, LTF, IL-1B, ADAM8, 
CAMK2A, RNF31, IRAK2, ICAM1, CFLAR, IL-6, TRIM25, 
MALT1, CD40, LGALS9, S100A12, TRIM38, CARD14, 
PSMA6, RIPK3, RIPK2, EIF2AK2, IKBKB 
type I interferon signaling pathway 0.000 
RNASEL, SP100, IFITM2, RSAD2, SAMHD1, OAS2, STAT1, 
IFI35, PSMB8, ISG20, STAT2, TYK2, IRF9, IFIT3, IFNAR2, 
IFIT2, IFI27, ISG15, IRF7, IRF1, XAF1, MX1, MX2, IFI6, 
ADAR 
apoptotic process 0.000 
S100A8, FAM3B, IL19, S100A9, TLR2, FOXO1, NFKB1, 
DAXX, ASAH2, CASP3, CASP4, UNC5B, CXCR4, CASP7, 
CASP8, MAP3K8, IL-1B, FAS, CASP1, MX1, IL1A, MT3, 
BCL2L15, BCL2L14, NCF1, GZMA, ARHGEF6, PIM1, 
RHBDD1, AHR, TNFRSF9, CARD14, CLIC4, ARRB1, 
TNFAIP8, RIPK2, AVEN, CTSC, NAIP, TNFAIP3, 
PPP1R15A, TRAF1, ZFAND6, ARL6IP1, TNFRSF21, 
GSDMA, LITAF, ADORA2A, SAV1, PML, EGLN3, NFKBIA, 
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RFFL, PRUNE2, PTK2B, SQSTM1, MAP3K1, ZC3H12A, 
XAF1, EPO, CFLAR, RNF144B, RMDN3, BIRC7, CHI3L1, 
TMBIM4, GJB6, STAT1, BIRC3, TNFSF9, DRAM2, 
RPS6KA3, TNFSF10, RASSF6, RABEP1, IFT57, SLC5A8, 
IRF1, JAK2, EAF2, DRAM1, CD14 
innate immune response 0.000 
S100A8, TBK1, S100A9, TLR2, TLR3, TLR4, NFKB1, 
NFKB2, TLR6, TRIM5, MAP3K5, NOD2, CASP4, PGLYRP4, 
CLEC4E, TRIM8, PGLYRP2, PGLYRP3, VNN1, MX1, MX2, 
LYN, NCF2, BPIFA1, NCF1, RELB, HERC5, SERPING1, 
IFI16, TYK2, STYK1, RIPK2, NAIP, MST1R, EIF2AK2, 
IL36A, FRK, IFIH1, FGR, CSF1, PML, TRIM14, C1R, IL34, 
TRIM10, CLEC10A, SEC14L1, CYLD, PTK2B, C2, DHX58, 
ZBP1, MALT1, TRIM25, TRIM21, S100A12, IL36RN, 
DDX58, CYBA, IRF7, IFIT5, JAK2, CLEC7A, IKBKB, CD14, 
ADAR 
interferon-gamma-mediated signaling pathway 0.000 
CIITA, ICAM1, SP100, NMI, PML, TRIM25, OAS2, STAT1, 
TRIM21, IRF9, VCAM1, TRIM38, TRIM5, CD44, TRIM8, 
TRIM34, IRF7, MT2A, IRF1, CAMK2D, JAK2, CAMK2B, 
CAMK2A 
immune response 0.000 
AQP9, IL19, TLR2, TNFSF15, TLR4, ZEB1, TLR6, VIPR1, 
TAPBP, CXCL10, TNFRSF11B, SH2D6, LTB4R, IL-1B, FAS, 
LTB, IL1A, CIITA, IL18RAP, GZMA, ACKR4, CD40, 
PDCD1LG2, TNFRSF9, TNFSF13B, CTSC, IL36A, CSF3, 
IL1R2, TNFRSF21, CCL2, LST1, TNF, CXCL5, IFITM2, C3, 
CXCL3, CXCL2, CXCL8, C1R, CX3CL1, OAS2, CCL5, 
CCL28, LIF, CCL22, CCL20, LY75, IL18R1, IL-6, TNFSF4, 
CEBPB, IL1RN, SMAD3, SAMHD1, TNFSF9, LAT, IKBKE, 
TNFSF10, CD274, AIRE, IFI6 
defense response to virus 0.000 
RNASEL, APOBEC1, IFITM2, TBK1, PML, TLR3, RSAD2, 
IFI44L, OAS2, ISG20, CXCL10, TRIM5, ISG15, ZC3H12A, 
MX1, MX2, DHX58, IL-6, HERC5, SAMHD1, TRIM25, IFI16, 
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CD40, STAT1, STAT2, IRF9, IFIT3, IFNAR2, IFIT2, TRIM34, 
IFIT5, IRF1, SLFN11, EIF2AK2, ADAR 
response to virus 0.000 
IFIH1, TNF, TNFSF4, FGR, TBK1, IFITM2, RSAD2, IFI44, 
OAS2, CCL5, ISG20, IFIT3, DDX58, IFNAR2, IFIT2, IRAK3, 
CCL22, CXCR4, IRF7, BCL3, MST1R, EIF2AK2, MX1, 
IKBKB, XCL1, MX2, DHX58, ADAR 
response to lipopolysaccharide 0.000 
TNFRSF21, S100A8, CXCL5, PTGS2, CXCL3, EDN1, 
CXCL2, DUSP10, TLR2, TLR4, CNP, NFKB2, CXCL10, 
VCAM1, IRAK3, CASP3, TNFRSF11B, PTGES, CASP8, FAS, 
CASP1, EPO, SELP, PTGER2, CD40, GJB6, IDO1, LGALS9, 




 Table 4.2 Gene Ontology Biological Process Direct for genes down-regulated in bovine endometrial 
epithelial cells treated with 100ng/mL of bovine LGALS1 in 3-D culture 
    
Down Biological Process P Value Genes 
 
DNA replication 0.000 
CLSPN, CHEK1, POLA2, MCM10, CDT1, RHNO1, ORC1, 
FEN1, RECQL4, CDC7, CDC6, DTL, GINS3, MCM2, MCM4, 
CDK2, MCM5, MCM6, RFC3, RFC4, RRM2, POLD1, RRM1, 
PCNA, CHTF18, CHAF1A, CHAF1B, BARD1 
G1/S transition of mitotic cell cycle 0.000 
CDC7, CDC6, SKP2, POLA2, MCM2, MCM10, MCM4, 
CDK2, MCM5, CDT1, MCM6, PRIM1, CCNE2, CCNE1, 
INHBA, PLK2, RRM2, PCNA, ORC1 
DNA replication initiation 0.000 CDC7, PRIM1, CCNE2, CCNE1, CDC6, MCM2, POLA2, MCM10, MCM4, ORC1, MCM5, MCM6 
DNA strand elongation involved in DNA replication 0.000 GINS1, PRIM1, RFC3, RFC4, POLD1, GINS3, PCNA, POLA2 
telomere maintenance via recombination 0.000 PRIM1, RFC3, RFC4, POLD1, PCNA, BRCA2, POLA2, FEN1 
positive regulation of transcription from RNA polymerase II 
promoter 0.000 
E2F1, AKNA, WNT5A, GLIS3, ELF5, E2F8, ARNT2, PPARG, 
FSTL3, PRRX1, TGFB3, MYBL2, SRF, MEIS1, IL11, JADE1, 
PAX8, PSIP1, RARA, NFATC2, TCF3, ETV4, BCL9, CYR61, 
CEBPA, EGR1, FZD8, FOSB, LPIN1, CAPRIN2, HDAC5, 
DOT1L, HES1, INHBA, UHRF1, HNF4A, JUN, SALL1, 
HOXB9, PIAS2, BMP7 
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cell division 0.000 
HAUS4, CDC7, CDC6, DSN1, KNTC1, SPDL1, SMC2, WEE1, 
CDK2, RGS14, MCM5, CCNE2, CCNE1, SPC25, VRK1, 
CENPV, SKA2, KLHL42, HELLS, TERF1 
regulation of transcription involved in G1/S transition of mitotic cell 
cycle 0.000 CCNE1, CDC6, RRM2, PCNA, ORC1, CDT1 










    
    
Up Biological Process P Value Genes 
 
TNF signaling pathway 0.000 
TRAF1, CCL2, TNF, PTGS2, CXCL3, CSF1, EDN1, CXCL2, 
NFKBIA, NFKB1, CX3CL1, CCL5, CXCL10, LIF, VCAM1, 
BAG4, CASP3, MAP3K5, NOD2, CCL20, CASP7, CASP8, 
MAP3K8, BCL3, IL-1B, PIK3R5, FAS, ICAM1, IL18R1, 
CFLAR, IL-6, CEBPB, MAP2K1, MAPK10, BIRC3, RIPK3, 
TNFAIP3, IKBKB 
Influenza A 0.000 
XPO1, IFIH1, RNASEL, CCL2, TNF, TBK1, NFKBIB, 
PML, CXCL8, NFKBIA, TLR3, RSAD2, NFKB1, TLR4, 
OAS2, CCL5, CXCL10, IL-1B, PIK3R5, FAS, CASP1, 
MX1, IL1A, CIITA, ICAM1, TMPRSS2, IL-6, MAP2K1, 
DDX39B, TRIM25, MAPK10, STAT1, STAT2, TYK2, 
IRF9, DDX58, IKBKE, IFNAR2, TNFSF10, IRF7, JAK2, 
IKBKB, EIF2AK2, ADAR   
NF-kappa B signaling pathway 0.000 
TRAF1, TNF, PTGS2, CXCL8, NFKBIA, NFKB1, TLR4, 
NFKB2, VCAM1, IL-1B, LTB, BLNK, ICAM1, CFLAR, LYN, 
RELB, BCL2A1, TRIM25, MALT1, CD40, BIRC3, DDX58, 
LAT, TNFSF13B, IKBKB, TNFAIP3, CD14, PLAU 
Cytokine-cytokine receptor interaction 0.000 
CSF3, IL1R2, TNFRSF21, CCL2, TNF, CXCL5, IL-6ST, 
OSMR, CXCL3, CSF1, IL21R, CXCL2, IL19, TNFSF15, 
CXCL8, CX3CL1, CCL5, TNFSF18, CCL28, CXCL10, LIF, 
TNFRSF11B, CCL22, CCL20, CXCR4, IL15RA, IL-1B, 
FAS, IL13RA1, LTB, IL1A, EPO, IL18R1, IL-6, IL2RB, 
IL18RAP, TNFSF4, ACKR3, CD40, TNFSF9, IFNAR2, 
TNFRSF9, TNFSF10, TNFSF13B, IL20RA, CXCL16, 
XCL1, IL3RA  
Table 4.3 KEGG Pathway Analysis for genes up-regulated in bovine endometrial epithelial cells 
treated with 100ng/mL of bovine LGALS1 in 3-D culture 
68 
 
Herpes simplex infection 0.000 
TRAF1, IFIH1, RNASEL, CCL2, TNF, TBK1, C3, NFKBIB, 
C5, TLR2, PML, NFKBIA, TLR3, NFKB1, OAS2, CCL5, 
DAXX, CASP3, TAP2, CASP8, TAP1, IL-1B, FAS, IL-6, 
SP100, TAF4B, NECTIN2, MAPK10, STAT1, STAT2, 
DDX58, IRF9, TYK2, IKBKE, IFNAR2, IRF7, JAK2, 
EIF2AK2, IKBKB  
Measles 0.000 
IFIH1, TBK1, NFKBIB, STAT5A, TLR2, NFKBIA, NFKB1, 
TLR4, OAS2, IL-1B, PIK3R5, FAS, MSN, MX1, IL1A, IL-6, 
IL2RB, STAT1, STAT3, STAT2, DDX58, IRF9, TYK2, 
IKBKE, IFNAR2, TNFSF10, IRF7, JAK2, EIF2AK2, 
TNFAIP3, ADAR  
NOD-like receptor signaling pathway 0.000 
IL-6, TNF, CCL2, NFKBIB, CXCL2, CXCL8, NFKBIA, 
NFKB1, MAPK10, BIRC3, CCL5, NOD2, CASP8, RIPK2, IL-
1B, NAIP, IKBKB, CASP1, TNFAIP3 
Pertussis 0.000 
IL-6, TNF, GNAI3, CXCL5, C3, GNAI1, C5, CXCL8, NFKB1, 
TLR4, C1R, SERPING1, MAPK10, CASP3, CASP7, IRF1, IL-
1B, NOS2, C2, CASP1, CD14, IL1A 
RIG-I-like receptor signaling pathway 0.000 
IFIH1, TNF, TBK1, NFKBIB, CXCL8, NFKBIA, NFKB1, 
TRIM25, MAPK10, TANK, CXCL10, DDX58, RNF125, 
IKBKE, CYLD, ISG15, IRF7, MAP3K1, CASP8, IKBKB, 
DHX58  
Toll-like receptor signaling pathway 0.000 
TNF, TBK1, TLR2, CXCL8, TLR3, NFKBIA, TLR4, 
NFKB1, CCL5, TLR6, CXCL10, MAP3K8, CASP8, IL-1B, 
PIK3R5, IL-6, MAP2K1, CD40, MAPK10, STAT1, IFNAR2, 
IKBKE, CD80, IRF7, IKBKB, CD14  
   




 Table 4.4 KEGG Pathway Analysis for genes down-regulated in bovine endometrial epithelial cells 
treated with 100ng/mL of bovine LGALS1 in 3-D culture 
    
Down Biological Process P Value Genes 
 
DNA replication 0.000 PRIM1, RFC3, RFC4, POLD1, PCNA, MCM2, POLA2, MCM4, MCM5, FEN1, MCM6 
Cell cycle 0.000 
CDC7, E2F1, CDC6, SKP2, TGFB3, CHEK1, MCM2, MCM4, 
WEE1, CDK2, MCM5, MCM6, CCNE2, CCNE1, PCNA, 
GADD45B, ORC1 
Pathways in cancer 0.000 
WNT5A, E2F1, FGFR3, PDGFA, ARNT2, PPARG, TGFB3, 
KITLG, FGF13, CCNE2, CCNE1, IGF1R, PAX8, PLEKHG5, 
RARA, LAMB1, CEBPA, FZD8, PTGER3, FZD1, SKP2, 
BRCA2, CDK2, WNT2B, WNT7B, PLCG1, JUN 
Signaling pathways regulating pluripotency of stem cells 0.000 WNT5A, INHBB, FZD8, IGF1R, INHBA, WNT7B, FGFR3, PCGF6, FZD1, TCF3, MEIS1, WNT2B 
HTLV-I infection 0.000 
WNT5A, EGR1, E2F1, FZD8, PDGFA, FZD1, TGFB3, 







Acc. Number Gene Primer Primer Sequence (5’-3’) 
Product 
Size (bp) Amp. E. Source of Primer 
NM_174301.3 CXCR4 Forward AAGGCTCAGAAGCGCAAG 102 102.21% (Weiner et al., 2012) 
  Reverse GAGTCGATGCTGATCCCAAT    
NM_015459645.2 MST1R Forward GAAAAGGGCGTAGAGCACTG 195 107.23% Primer3Plus 
  Reverse CAACAGCCCGTTGAATAGGT    
NM_025000176.1 ATP11A Forward GGTGATGGTGCTCACAGTCA 133 98.64% Primer3Plus 
  Reverse CCAGATGACTCCTCCCCAGA    
XM_024986067.1 CHST15 Forward TCTGCTCTCTTGTGTGCGAG 119 97.08% Primer3Plus 
  Reverse CCTGGGTAGTGAGAGAGGCT    
NM_173923.2 IL-6 Forward CGCATGGTCGACAAAATCTCT 69 95.37% (Mathew et al., 2019) 
  Reverse GCTGCTTTCACACTCATCATTCTT    
NM_174093.1 IL-1B Forward ACCTGAACCCATCAACGAAATG 74 92.97% (Mathew et al., 2019) 
  Reverse TAGGGCCATCAGCCTCAAATAACA    
NM_173931.1 LIF Forward GGGACAACTCAACAGCAGTG 91 96.00% Primer3Plus 
  Reverse GCACAGCTTGTCCAGGTTG    
NM_001191149.1 EIF4EBP2 Forward GGGTTCAGCATCATTCCTGT 227 107.99% Primer3Plus 
  Reverse GGGAAGTGGACCTCAAAACA    
NM_178320 PPIA Forward CATACAGGTCCTGGCATCTTGTCC 108 -  
  Reverse CACGTGCTTGCCATCCAACC    
NM_174814.2 YWHAZ Forward ACCTACTCCGGACACAGAACATC 65 -  
  Reverse GCAGGAGGGGCACGTGAAGG    
Table 4.5- Genbank accession number, gene name, primer sequence (forward and reverse), 











Figure 4.1 Diagram representing 3-D co-culture system of bovine endometrial epithelial 
and fibroblast cells. Epithelial cells were cultured on transwell inserts that were 
placed on top of fibroblast cells cultured in 24 well plates. Galectin-1 treatments (10 
or 100 ng/mL) were applied to the transwell insert containing epithelial cells and 































































Figure 4.2 Least squares means relative expression values for CXCR4 in endometrial 
epithelial (A) and fibroblast (B) cells in 3-D culture (n=4) treated with increasing 
concentrations of LGALS1 (Control, 10 or 100 ng/mL). There was a significant 
effect of treatment in epithelial cells (Contrast; P < 0.05) when all LGALS1 
treatments were compared to Control. Epithelial SEM = 0.89. Fibroblast SEM = 
0.02. 
CXCR4 
SEM = 0.02 


































































Figure 4.3 Least squares means relative expression values for EIF4EBP2 in endometrial epithelial (A) and 
fibroblast (B) cells in 3-D culture (n=4) treated with increasing concentrations of LGALS1 (Control, 
10, or 100 ng/mL). There was a significant effect of treatment in epithelial and fibroblast cells 
(Contrast; P < 0.001) when all LGALS1 treatments were compared to Control. Epithelial SEM = 
0.18. Fibroblast SEM = 0.17. 
SEM = 0.17 









































Figure 4.4 Least squares means relative expression values for IL-1B in endometrial epithelial 
(A) and fibroblast (B) cells in 3-D culture (n=4) treated with increasing concentrations 
of LGALS1 (Control, 10, or 100 ng/mL). There was a significant effect of treatment in 
epithelial cells (Contrast; P < 0.001) when all LGALS1 treatments were compared to 





























SEM = 0.08 
































































Figure 4.5 Least squares means relative expression values for IL-6 in endometrial 
epithelial (A) and fibroblast (B) cells in 3-D culture (n=4) treated with 
increasing concentrations of LGALS1 (Control, 10, or 100 ng/mL). There 
was a significant effect of treatment in epithelial cells (Contrast; P < 0.01) 
when all LGALS1 treatments were compared to Control.  Epithelial SEM = 
1.33. Fibroblast SEM = 0.36. 
IL-6 
** 
SEM = 0.36 





































































Figure 4.6 Least squares means relative expression values for LIF in endometrial 
epithelial (A) and fibroblast (B) cells in 3-D culture (n=4) treated with 
increasing concentrations of LGALS1 (Control, 10, or 100 ng/mL). There 
was a significant effect of treatment in fibroblast cells (Contrast; P < 0.05) 
when all LGALS1 treatments were compared to Control.   In Epithelial cells 
SEM = 0.09. Fibroblast SEM = 0.17. 
* 
SEM = 0.09 




































































Figure 4.7 Least squares means relative expression values for CHST15 in endometrial 
epithelial (A) and fibroblast (B) cells in 3-D culture (n=4) treated with increasing 
concentrations of LGALS1 (Control, 10, or 100 ng/mL). There was a significant 
effect of treatment in fibroblast cells (Contrast; P < 0.01) when all LGALS1 
treatments were compared to Control. Epithelial SEM = 0.21 Fibroblast SEM = 
0.93. 
** 
SEM = 0.21 

































































Figure 4.8 Least squares means relative expression values for MST1R in endometrial 
epithelial (A) and fibroblast (B) cells in 3-D culture (n=4) treated with increasing 
concentrations of LGALS1 (Control, 10, or 100 ng/mL). There was a significant 
effect of treatment in fibroblast cells (Contrast; P < 0.01) when all LGALS1 




SEM = 0.53 





































































Figure 4.9 Least squares means relative expression values for ATP11a in endometrial 
epithelial (A) and fibroblast (B) cells in 3-D culture (n=4) treated with increasing 
concentrations of LGALS1 (Control, 10, or 100 ng/mL). There was a significant 
effect of treatment in epithelial and fibroblast cells (Contrast; P < 0.001) when all 
LGALS1 treatments were compared to Control. Epithelial SEM = 0.68.  Fibroblast 
SEM = 0.63. 
*** 
*** 
SEM = 0.68 











  Treatment   Contrast 
Gene Cell Type Control 10 100 SEM TRT C 
CHST15 Epi 0.82ab 0.42a 1.10b 0.21 NS NS 
 Fib 3.86a 1.41b 1.16b 0.93 ≤0.01 ≤0.001 
CXCR4 Epi 6.12a 6.15a 13.77b 0.89 ≤0.01 ≤0.05 
 Fib 0.16 0.11 0.12 0.02 NS NS 
EIF4EBP2 Epi 2.43a 0.93b 1.04b 0.18 ≤0.001 ≤0.001 
 Fib 2.06a 0.88b 0.83b 0.17 ≤0.001 ≤0.001 
IL-1B Epi 0.40a 21.41b 265.44c 34.95 ≤0.001 ≤0.001 
 Fib 0.28 0.32 0.37 0.08 NS NS 
IL-6 Epi 1.74a 3.18b 4.89b 1.33 ≤0.01 ≤0.01 
 Fib 1.32 1.21 1.55 0.36 NS NS 
LIF Epi 8.21a 8.42a 14.71b 1.92 NS NS 
 Fib 0.79a 0.48b 0.52b 0.28 NS ≤0.05 
MST1R Epi 4.44ab 2.00a 6.29b 1.33 NS NS 
 Fib 3.79a 2.53b 2.60b 0.53 ≤0.05 ≤0.01 
ATP11a Epi 8.42a 3.03b 2.66b 0.68 ≤0.001 ≤0.01 
 Fib 3.40a 1.82b 1.72b 0.63 ≤0.001  ≤0.01  
Table 4.6 Summary of relative expression data for genes amplified by RT-qPCR in 
endometrial epithelial cells and fibroblast cells treated with LGALS1. Data are 
presented as LSM + SEM. P-values are that of the log-transformed data. Contrast: 











 This study investigated the gene expression of pregnant and cyclic bovine endometrium 
near the time of maternal recognition of pregnancy to better understand the immune environment 
during that time. Crossbred beef heifers (Angus X Hereford) were synchronized using a 7-day 
fixed-time artificial insemination (FTAI) protocol. Heifers were either inseminated (n=4) or left 
as an uninseminated Controls (n=4). On embryonic day 16, inseminated cows were sacrificed 
and embryos and tissue samples were collected. On Day 17 control animals were slaughtered for 
collection of tissue samples. Endometrial RNA was extracted and cDNA synthesized. 
Endometrial gene expression for potential regulatory T cell (Treg) factors (FOXP3, IL-2RA, and 
LGALS1) and other immune related genes considered important for pregnancy (CXCR4, IL-1B, 
IL-6, and LIF) were measured by RT-qPCR. Although effect of pregnancy did not affect genes 
expression, a tendency was observed for in expression of IL-1B and IL-6 (P = 0.09) compared to 
control endometrium. Expression of IL-1B tended (P = 0.09) to increase compared to control 
endometrium and IL-6 and expression tended (P = 0.09) to decrease in endometrium of pregnant 
heifers. 
INTRODUCTION 
 In order to understand the mechanics behind early embryonic loss in cattle, this study 
measured endometrial genes considered important for reproduction. Studies have shown that 
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endometrial gene expression is regulated mainly by the actions of progesterone (P4) and 
conceptus secretory proteins (CSP), especially interferon tau (IFNT) (Gray et al., 2006). Most of 
the bovine CSP are unknown but are believed to also modify endometrial gene expression 
(Clemente et al., 2009). This study investigated the expression of those genes that were modified 
in bovine endometrium treated with CSP LGALS1 (Chapters III and IV) in pregnant and cyclic 
bovine endometrium. The gene CXCR4 is activated during implantation and placentation in 
sheep and likely plays a role in the communication between trophoblast cells and the maternal 
endometrium as well as in placental angiogenesis (Ashley et al., 2011, Fry et al., 1992, Mathew 
et al., 2016, Laird et al., 1997, Laird et al., 2000). Genes FOXP3, LGALS1, and IL-2RA are 
related to regulatory T-cell (Treg) activity. In rodents, the CSP, LGALS1 has been shown to 
promote proliferation of Treg and reduce fetal loss by inducing fetomaternal tolerance (Blois et 
al., 2007). The presence of Treg has not been confirmed in bovine endometrium. Endometrial 
expression of genes IL-1B, IL-6, and LIF of which are regulated by the transcription factor, 
nuclear factor kappa B (NFKB), and are believed to be important for the maintenance of 
pregnancy, implantation, and conceptus viability in sheep, cattle, humans, and rodents (Ashley et 
al., 2011). These differences in expression could be coding for proteins that are essential for 
pregnancy recognition and the maintenance of a successful pregnancy at this time.  The genes 
chosen have roles in modulation of the immune system, are important for conceptus attachment, 
and may be important in the formation of the placenta (Blois et al., 2007, Mathialagan et al., 
1992, Laird et al., 2000). We hypothesize that the genes investigated will increase in the 
endometrium of pregnant heifers when compared to the endometrium of non-pregnant heifers.  
MATERIALS AND METHODS 
Animals and Tissue Collection 
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 The reproductive cycles of crossbred beef heifers (Hereford and Angus), located on the 
West Virginia University Animal Science Farm were synchronized using a 7-day FTAI protocol. 
Synchronization carried out by administering P4 intravaginally for 7 days (Controlled Internal 
Drug Release; CIDR; 1.38g P4; Zoetis Animal Health, Parsippany, NJ). On day of CIDR 
insertion, 2 mL of gonadotropin releasing hormone (GnRH; Factrel; containing 100 mcg 
gonadorelin; Zoetis Animal Health) was administered by intramuscular injection (IM). On day of 
CIDR removal (day 0) 5 mL prostaglandin-F2-alpha (PGF2α ; Lutalyse; 5mg dinoprost/mL; 
Zoetis Animal Health) was administered by IM. Heifers then received a second injection of 
GnRH and were inseminated (n=4) or left uninseminated (n=4) approximately 52-56 hours after 
CIDR removal. Bred heifers were slaughtered on embryonic day 16 while uninseminated heifers 
were slaughtered on day 17 at Young and Stout Wholesale Meats and Provisions in Bridgeport, 
West. Immediately following slaughter, reproductive tracts were sprayed with 70% EtOH and 
the broad ligament of the uterus was dissected away. The uterine horns were flushed twice, using 
a total of 20 mL 1X Dulbecco’s Phosphate-Buffered Saline (DPBS; Gibco, Gaithersburg, MD). 
Day 16 conceptuses were measured, snap frozen in liquid nitrogen and stored at -80°C. 
Endometrium was then dissected from the intercaruncular regions of the uterine horn ipsilateral 
to the corpus luteum (CL), snap frozen, and stored at -80°C until RNA extraction.  
RNA Extraction 
Total RNA was extracted from pregnant and open intercaruncular endometrium samples 
that were previously snap frozen. In order to homogenize the tissue, the sample was placed in a 
Mini-Beadbeater-24 (Biospec Products; Bartlesville, OK) for 2 min containing 1 mL of Trizol 
reagent and a 5 mm bead.  Following homogenization, E.Z.N.A. Total RNA Kit I (Omega Bio-
tek, Norcross, GA) was used per the manufacturer’s instructions to extract RNA. On-column 
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RNA clean-up was performed. The quantity of RNA was then determined using the NanoDrop 
1000 (Thermo Fisher Scientific). 
RT-qPCR 
Explant mRNA (500 ng) was reverse transcribed into cDNA using the High-capacity 
cDNA Reverse Transcription Kit (Applied Biosystems; Foster City, CA) in a 20 μL reaction 
following the manufacturer’s recommendation. The RT-qPCR reactions were carried out using 
PowerUp SYBR Green Master Mix (Applied Biosystems) and the C1000 Touch Thermal Cycler 
(Bio-Rad; Hercules, CA). The RT-qPCR thermo cycler settings for all reactions consisted of an 
initial temperature of 50°C for 2 min, 95°C for 2 min followed by 40 PCR cycles consisting of 
melting at 95°C for 15 sec and annealing and extension at 60°C for 1 min. Primers were created 
using Primer3Plus or obtained from previously published research. The PCR primer 
amplification efficiencies (E) for each PCR target sequence were calculated from the standard 
curve generated from seven cDNA dilutions. The equation used for the efficiency calculation 
was E = [10(-1/slope) -1]. Percent efficiency was calculated by dividing E by 2 and then multiplying 
by 100. Only primers with effiencies between 90-110% were used. A dissociation analysis was 
included for each primer pair to evaluate primer specificity for the target sequence. Gel 
electrophoresis was performed using PCR products in a 3% agarose gel to further confirm the 
primers by amplicon size. The qbase+ computer program (Biogazelle; Zwijnaarde, Belgium) was 
used to calculate the normalized relative expression quantities (NRQ; relative expression) of 
target genes based on a generalized delta-delta quantification cycle method (ΔΔCq; also known 
as ΔΔCT) (Hellemans et al., 2007). To identify potential normalization targets, RT-qPCR was 
carried out for eight potential genes across a subset of samples representing all treatments. Genes 
H3 Histone Family Member 3A (H3F3A) and Ring Finger Protein 11 (RNF11) were found to be 
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the most stably expressed across treatments using the geNorm analysis (geNorm M < 0.25) 
(Vandesompele et al., 2002).  
Statistical Analysis 
A general linear model procedure (proc GLM) in the statistical analysis software (SAS) 
was used to test for an effect of pregnancy on relative gene expression data. All data are 
presented in their original format; however, all p-values are that of the log base 10 (log10) 
transformation. Data are presented as least square means + standard error of LSM (LSM + 
SEM). Significance was declared at P < 0.05. 
RESULTS 
 There was not an effect of pregnancy on the endometrial gene expression of CXCR4, 
FOXP3, LGALS1, IL-1B, IL-2RA, IL-6, or LIF. However, there was a tendency (P = 0.09) for an 
effect of pregnancy on expression of IL-1B and IL-6.  Expression of IL-1B tended to increase and 
IL-6 tended to decrease in pregnant endometrium.  
DISCUSSION 
 These genes LGALS1, IL2-RA, LIF, CXCR4, and IL-1B were measured because of their 
known importance during pregnancy in mammals and because they were differentially expressed 
in response to galectin-1 (LGALS1), a protein secreted by the developing bovine conceptus in 
Chapters III and IV. We did not detect significant effect of pregnancy on expression of genes 
LGALS1, IL2-RA, LIF, CXCR4, and IL-1B however, their level of expression did increase 
numerically. We observed similar trends in endometrial explants (Chapter III) and in cultured 
epithelial cells (Chapter IV) treated with LGALS1. The genes FOXP3 and IL-6 expression was 
decreased in the current study which does not follow the pattern shown in explants treated with 
LGALS1 (Chapter III).  
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 Studies have shown in other species, such as sheep, that CXCR4 and LIF are up-regulated 
in pregnant endometrium compared to non-pregnant (Ashley et al., 2011, Vogiagis et al., 1997). 
In cattle, an increase in LIF was observed in day 13 pregnant endometrium when compared to 
cyclic endometrium. Other studies have also found differential expression of LGALS1 in 
pregnant human and rodent endometrium (Phillips et al., 1996, Bevan et al., 1994). Galectin-1 
mRNA has been detected in day 16 bovine endometrium and conceptus (Mamo et al., 2012). 
Based on our findings in the previous studies (Chapters III and IV), along with those published 
by (Blois et al., 2007), brought us to hypothesize that Treg markers, IL-2RA and FOXP3, might 
increase in the bovine endometrium during early pregnancy. Decreased expression of the genes 
IL-6 and IL-1B have been associated with habitual abortion in women (Wolff et al., 2000). In 
ruminants IL-1B is an adhesion molecule in the IL-1 family and has been found to be produced 
by the embryo, trophoblast and endometrium (Mathialagan et al., 1992). The cytokine IL-1 has 
been shown to increase LIF and IL-6 production in endometrial epithelial cells (Laird et al., 
2000) In mice, pigs, sheep, and cattle, IL-6 has been shown to be produced by the trophoblast 
(Mathialagan et al., 1992). IL-6 may be playing a role in chorionic placentation because it 
increases the permeability of endothelial cells and increases the production of complement 
inhibitors and proteases (Martal et al., 1997, Maruo et al., 1992).   
 There are many factors that could possibly be contributing to the reasons our results were 
not significant or reasons that gene expression patterns did not align with our previous studies. 
The first could be that the concentrations of LGALS1 used in 3-D and explant cultures did not 
match the physiological concentrations of the protein present in the bovine uterus during early 
pregnancy. Intrauterine concentration of LGALS1 of any species is unknown. A human study 
measured serum concentrations of LGALS1 and were found to be 36.9 + 7.8 ng/mL in normal 
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healthy serum donors (Ouyang et al., 2013). Another reason could be that when collecting 
endometrium, we did not by chance, collect tissue adjacent to the conceptus thus, the 
endometrium had reduced expression levels. The conceptuses were approximatley 10- 15 cm in 
length when completely stretched out and only a couple millimeters in width. The uterine horn in 
beef heifers is between 23-27 cm in length which creates ample space for the conceptus to be 
located (Drennan and Macpherson, 1966). Improvements could be made in future research with 
methods of collecting samples adjacent to the location of the conceptus, and by including more 
animals in the study to increase the power.   
CONCLUSION 
 In conclusion, we did not detect expression of potential conceptus induced genes CXCR4, 
FOXP3, LGALS1, IL-1β, IL-2RA, IL-6, and LIF in pregnant compared to cyclic endometrium. 
There were tendencies (P = 0.09) for an effect of pregnant status on IL-6 and IL-1β. Further 
investigation of conceptus- maternal interaction during early pregnancy in cattle will increase our 
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Figure 5.1- Experimental design. 7-day fixed time AI protocol. Pregnant animals were slaughtered 




Acc. Number Gene Primer Primer Sequence (3’-5’) 
Product 
Size (bp) Amp. E. 
Source of Primer 
NM_174301.3 CXCR4 Forward AAGGCTCAGAAGCGCAAG 102 102.21% (Weiner et al., 2012) 
  Reverse GAGTCGATGCTGATCCCAAT    
NM_174358.2 IL-2RA Forward ACATCGGCAGTGGTCTCAG 59 109.13% (Zoldan et al., 2014) 
  Reverse GAACCTCCACATCAGCAAGC    
NM_175782.1 LGALS1 Forward GTGGCCGCAGACGCCAAGAG 98 93.67% (Okumu et al., 2011) 
  Reverse ACGTCCCCATGCGCGTTGAAA    
NM_001045933.1 FOXP3 Forward TGGTGCTGGAGAAGGAGAAG 92 100.56% (Mathew et al., 2018) 
  Reverse GTCAGATGATGCCGCAGATG    
NM_173923.2 IL-6 Forward CGCATGGTCGACAAAATCTCT 69 95.37% (Mathew et al., 2019) 
  Reverse GCTGCTTTCACACTCATCATTCTT    
NM_174093.1 IL-1B Forward ACCTGAACCCATCAACGAAATG 74 92.97% (Mathew et al., 2019) 
  Reverse TAGGGCCATCAGCCTCAAATAACA    
NM_173931.1 LIF Forward GGGACAACTCAACAGCAGTG 91 96.00% Primer3Plus 
  Reverse GCACAGCTTGTCCAGGTTG    
NM_001014389.2 H3F3A Forward CATGGCTCGTACAAAGCAGA 136 -  
  Reverse ACCAGGCCTGTAACGATGAG    
NM_001077953.1 RNF11 Forward TCCGGGAGTGTGTGATCTGTATGAT 131 -  
  Reverse GCAGGAGGGGCACGTGAAGG    
       
Table 5.1 Genbank accession number, gene name, primer sequence (forward and reverse), product size, 






























Figure 5.2 Least squares means relative expression values for CXCR4 in day 16 
pregnant (n=4) and day 17 cyclic (n=4) endometrium. There was not a 



























Figure 5.3 Least squares means relative expression values for FOXP3 in day 16 
pregnant (n=4) and day 17 cyclic (n=4) endometrium. There was not a 


























Figure 5.4 Least squares means relative expression values for LGALS1 in day 16 
pregnant (n=4) and day 17 cyclic (n=4) endometrium. There was not a 


























Figure 5.5 Least squares means relative expression values for IL-1B in day 16 
pregnant (n=4) and day 17 cyclic (n=4) endometrium. There was a tendency 































Figure 5.6 Least squares means relative expression values for IL-2RA in day 16 
pregnant (n=4) and day 17 cyclic (n=4) endometrium. There was not a 


























Figure 5.7 Least squares means relative expression values for IL-6 in day 16 pregnant 
(n=4) and day 17 cyclic (n=4) endometrium. There was a tendency (P = 0.09) 























Figure 5.8 Least squares means relative expression values for LIF in day 16 pregnant 
(n=4) and day 17 cyclic (n=4) endometrium. There was not a significant effect 










 Based on the results presented and previously published findings, it is possible that 
LGALS1 secreted by the day 16 bovine conceptus is increasing the expression of transcription 
factor, FOXP3 which in turn, increases regulatory T cells (Treg) that express IL-2RA. The 
LGALS1 may also increase tolerogenic dendritic cells (DC) that express CD11c. Previous 
studies found that LGALS1 reduced fetal loss in sound stressed rodents possibly by increasing 
the presence of Treg in the uterus, thus suppressing the immune system and promoting 
fetomaternal tolerance (Blois et al., 2007).  Figure 6.1 illustrates the possibility that conceptus 
produced LGALS1 is increasing expression of NFKB transcription factor which causes increased 
expression of IL-1B. Increased IL-1B in turn, causes an increase in LIF. Increased NFKB is also 
possibly causing increased expression of IL-6. This hypothesis is supported by research that 
shows NFKB is involved in cellular signaling from IL-1 in many cell types (Martal et al., 1997). 
Research has also shown that IL-1 increases LIF production in endometrial epithelial cells of 
women (Laird et al., 2000). The promoter regions of LIF and IL-6 genes contain NFKB binding 
sites and expression of these cytokines in other cells has been shown to be controlled by NFKB 
(Van der Burg and Van der Saag, 1996). We hypothesize that LGALS1 secreted by the 
developing bovine conceptus is also causing an increase in the expression of CXCR4, possibly 
through the activation of NFKB. Previous studies in human kidney cancer patients showed that 
LGALS1 up-regulated CXCR4 gene expression though NFKB (Huang et al., 2014). Research in 
sheep have shown CXCR4 is activated during implantation and placentation (Ashley et al., 
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2011). The up-regulation of all of these genes leads to a potential role of LGALS1 in increased 
adhesion, increased implantation, increased invasiveness, increased immune modulation, and 















Endometrial Epithelial Cells 
Figure 6.1 Proposed pathway for the effect of conceptus produced LGALS1 on the endometrium during early 
pregnancy in cattle. In the epithelial cells of the endometrium, production of LGALS1 increases the 
transcription factor, NFKB, which in turn increases expression of IL-1B, IL-6, and CXCR4. The 
increased expression of IL-1B causes an increased expression of LIF. In the stroma of the 
endometrium, LGALS1 secretion from the conceptus also increases FOXP3 which in turn causes an 
increase in Treg cells. Tolergenic dendritic cells that express CD11c. are also increased. 
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STAINS OF BOVINE CARUNCULAR ENDOMETRIUM FOR FOXP3 AND CD4 PROTEIN 
INTRODUCTION 
In a previous study Mathew et al. (2018), caruncular bovine endometrium explants were treated 
with increasing concentrations of LGALS1. Galectin-1 increased expression of CD11c and 
FOXP3 as well as the number of FOXP3+ stained cells in the caruncular tissue. Because the 
number of FOXP3+ cells increased with increasing concentrations of LGALS1, they 
hypothesized that LGALS1 may promote expansion of dendritic cells (DC) and regulatory T-
cells (Treg) within the bovine endometrial caruncle, contributing to immune suppression at the 
fetal-maternal interface in cattle. The aim of this experiment was to co-localize FOXP3 and CD4 
protein in serial sectioned caruncular endometrial explants treated with LGALS1 using 
immunohistochemistry (IHC) in preparation of intercaruncular staining. 
MATERIALS AND METHODS 
Immunohistochemistry 
 Bovine caruncular tissue that was collected and treated with LGALS1 during a previous 
study was used for this experiment (Mathew et al., 2018). Caruncular tissue samples fixed in 
10% non-buffered formalin (NBF) and imbedded into paraffin blocks were sectioned to 5 μm 
thickness and mounted on charged glass slides. To begin tissue staining, the paraffin was 
removed using xylene, increasing serial dilutions of EtOH, distilled water, and 1X phosphate 
buffered solution (PBS). Slides were then placed into 0.01M Sodium Citrate Buffer, boiled for 6 
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min, and allowed to cool for 45 min on ice. Sections were then washed twice in 1X PBS for 5 
min each time. Tissues were incubated in 0.3% hydrogen peroxide in methanol for 30 min at 
room temperature then washed in 1X PBS for 5 min to block endogenous peroxidase activity. 
Blocking of non-specific binding was performed by using rabbit IgG (VECTASTAIN Elite 
ABC- Peroxidase Kit; Vector Labs; Burlington, ON, Canada) followed by Streptavidin/Biotin 
Blocking Kit (Vector Labs) were used per manufacturer’s instructions. A 1:25 dilution of mouse 
anti-bovine CD4 (initial concentration predicted to be 1.0 μg/mL; BioRad; Hercules, CA) to 1X 
PBS and 1:1000 dilution of rabbit anti-bovine FOXP3 (original concentration predicted to be 4-8 
μg/mL; Sigma Aldrich, St. Louis, MO) in 1X PBS was added to slides of serial tissue sections 
and incubated overnight at 4°C. Following incubation, slides were washed twice for 5 min each 
in 1X PBS and then the secondary antibody solution was added to slides (goat- FOXP3 or 
mouse- CD4, respectively) for 30 min. ImmPACT DABPeroxidase Substrate (Vector Labs) was 
used at a 3:100 dilution and added to slides for 1.5 min then rinsed in running tap water for 5 
min. Hematoxylin (Sigma Aldrich; St. Louis, MO) was used to stain slides by dipping them 3 
times, for 3 seconds each, rinsed with distilled water twice, then Scott’s tap water was added to 
tissues for 1 minute and slides were again placed in distilled water. Dehydration was performed 
by submerging slides in decreasing serial dilutions of EtOH. Slides were allowed to air dry, and 
Permount (Fisher Scientific; Hampton, NH) was used to mount glass cover slips. Slides were 
imaged using a Zeiss fluorescent microscope (Zeiss; Oberkochen, Germany) mounted with 
AxioCam ICc1 R 4 and AxioVision Rel 4.8.2 Software (Zeiss).   
RESULTS AND DISCUSSION 
 Immunohistochemisty resulted in staining of FOXP3 and CD4 cells in caruncular 
endometrial explants treated with LGALS1. Serial sections, one stained for FOXP3 and the other 
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for CD4, had apparent overlapping staining for a group of stromal cells, seemingly lymphocytes, 
based on size and morphology. Control slides were not included, therefore, the specificity of the 
antibodies cannot be confirmed.  In rodent endometrium, LGALS1 increases the number of Treg 
cellsthat express FOXP3 (Blois et al., 2007). Overlapping staining for FOXP3 and CD4 protein 
in bovine caruncular endometrium would provide evidence of Treg within the endometrium of 








Figure A.1- Immunohistochemistry using DAB staining of caruncular explant tissue 
treated with LGALS1. A- anti FOXP3 10X magnification. B- anti FOXP3 40x 
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Gene Ontology direct Pathways up-regulated in Epithelial Cells treated with 100ng/mL of LGALS1 
 
inflammatory response 0.000 
PTGS2, ELF3, S100A8, TBK1, IL19, S100A9, TLR2, TLR3, 
TLR4, NFKB1, NFKB2, TLR6, CXCL10, CCRL2, S1PR3, 
TNFRSF11B, CASP4, CXCR4, LTB4R, MGLL, IL-1B, VNN1, 
FAS, ADAM8, TNIP1, IL1A, CIITA, IRAK2, NFKBIZ, 
PTGER2, C5AR2, SP100, IL18RAP, GBP5, LYN, RELB, 
CHST2, CD40, IFI16, TNFRSF9, TNFAIP6, PTGDR, RIPK2, 
NAIP, TNFAIP3, IL36A, TNFRSF21, CCL2, NMI, TNF, 
CXCL5, C3, ADORA2A, CXCL3, CSF1, C5, CXCL2, CXCL8, 
CCL5, IL34, CCL22, CCL20, ITGB6, ZC3H12A, BLNK, LY75, 
SELP, IL-6, LIPA, CEBPB, OLR1, CHI3L1, SMAD1, 
LGALS9, S100A12, LAT, APOL3, CYBA, CLEC7A, IKBKB, 
CD14, F2R 
positive regulation of NF-kappaB transcription factor activity 0.000 
TRAF1, TNF, S100A8, NFKBIB, S100A9, TLR2, TRIM14, 
NFKBIA, TLR3, NFKB1, TLR4, NFKB2, TNFSF18, IRAK3, 
TRIM5, NOD2, TRIM8, RBCK1, LTF, IL-1B, ADAM8, 
CAMK2A, RNF31, IRAK2, ICAM1, CFLAR, IL-6, TRIM25, 
MALT1, CD40, LGALS9, S100A12, TRIM38, CARD14, 
PSMA6, RIPK3, RIPK2, EIF2AK2, IKBKB 
type I interferon signaling pathway 0.000 
RNASEL, SP100, IFITM2, RSAD2, SAMHD1, OAS2, STAT1, 
IFI35, PSMB8, ISG20, STAT2, TYK2, IRF9, IFIT3, IFNAR2, 
IFIT2, IFI27, ISG15, IRF7, IRF1, XAF1, MX1, MX2, IFI6, 
ADAR 
apoptotic process 0.000 
S100A8, FAM3B, IL19, S100A9, TLR2, FOXO1, NFKB1, 
DAXX, ASAH2, CASP3, CASP4, UNC5B, CXCR4, CASP7, 
CASP8, MAP3K8, IL-1B, FAS, CASP1, MX1, IL1A, MT3, 
BCL2L15, BCL2L14, NCF1, GZMA, ARHGEF6, PIM1, 
RHBDD1, AHR, TNFRSF9, CARD14, CLIC4, ARRB1, 
TNFAIP8, RIPK2, AVEN, CTSC, NAIP, TNFAIP3, 
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PPP1R15A, TRAF1, ZFAND6, ARL6IP1, TNFRSF21, 
GSDMA, LITAF, ADORA2A, SAV1, PML, EGLN3, NFKBIA, 
RFFL, PRUNE2, PTK2B, SQSTM1, MAP3K1, ZC3H12A, 
XAF1, EPO, CFLAR, RNF144B, RMDN3, BIRC7, CHI3L1, 
TMBIM4, GJB6, STAT1, BIRC3, TNFSF9, DRAM2, 
RPS6KA3, TNFSF10, RASSF6, RABEP1, IFT57, SLC5A8, 
IRF1, JAK2, EAF2, DRAM1, CD14 
innate immune response 0.000 
S100A8, TBK1, S100A9, TLR2, TLR3, TLR4, NFKB1, 
NFKB2, TLR6, TRIM5, MAP3K5, NOD2, CASP4, PGLYRP4, 
CLEC4E, TRIM8, PGLYRP2, PGLYRP3, VNN1, MX1, MX2, 
LYN, NCF2, BPIFA1, NCF1, RELB, HERC5, SERPING1, 
IFI16, TYK2, STYK1, RIPK2, NAIP, MST1R, EIF2AK2, 
IL36A, FRK, IFIH1, FGR, CSF1, PML, TRIM14, C1R, IL34, 
TRIM10, CLEC10A, SEC14L1, CYLD, PTK2B, C2, DHX58, 
ZBP1, MALT1, TRIM25, TRIM21, S100A12, IL36RN, 
DDX58, CYBA, IRF7, IFIT5, JAK2, CLEC7A, IKBKB, CD14, 
ADAR 
interferon-gamma-mediated signaling pathway 0.000 
CIITA, ICAM1, SP100, NMI, PML, TRIM25, OAS2, STAT1, 
TRIM21, IRF9, VCAM1, TRIM38, TRIM5, CD44, TRIM8, 
TRIM34, IRF7, MT2A, IRF1, CAMK2D, JAK2, CAMK2B, 
CAMK2A 
immune response 0.000 
AQP9, IL19, TLR2, TNFSF15, TLR4, ZEB1, TLR6, VIPR1, 
TAPBP, CXCL10, TNFRSF11B, SH2D6, LTB4R, IL-1B, FAS, 
LTB, IL1A, CIITA, IL18RAP, GZMA, ACKR4, CD40, 
PDCD1LG2, TNFRSF9, TNFSF13B, CTSC, IL36A, CSF3, 
IL1R2, TNFRSF21, CCL2, LST1, TNF, CXCL5, IFITM2, C3, 
CXCL3, CXCL2, CXCL8, C1R, CX3CL1, OAS2, CCL5, 
CCL28, LIF, CCL22, CCL20, LY75, IL18R1, IL-6, TNFSF4, 
CEBPB, IL1RN, SMAD3, SAMHD1, TNFSF9, LAT, IKBKE, 
TNFSF10, CD274, AIRE, IFI6 
defense response to virus 0.000 
RNASEL, APOBEC1, IFITM2, TBK1, PML, TLR3, RSAD2, 
IFI44L, OAS2, ISG20, CXCL10, TRIM5, ISG15, ZC3H12A, 
MX1, MX2, DHX58, IL-6, HERC5, SAMHD1, TRIM25, IFI16, 
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CD40, STAT1, STAT2, IRF9, IFIT3, IFNAR2, IFIT2, TRIM34, 
IFIT5, IRF1, SLFN11, EIF2AK2, ADAR 
response to virus 0.000 
IFIH1, TNF, TNFSF4, FGR, TBK1, IFITM2, RSAD2, IFI44, 
OAS2, CCL5, ISG20, IFIT3, DDX58, IFNAR2, IFIT2, IRAK3, 
CCL22, CXCR4, IRF7, BCL3, MST1R, EIF2AK2, MX1, 
IKBKB, XCL1, MX2, DHX58, ADAR 
response to lipopolysaccharide 0.000 
TNFRSF21, S100A8, CXCL5, PTGS2, CXCL3, EDN1, 
CXCL2, DUSP10, TLR2, TLR4, CNP, NFKB2, CXCL10, 
VCAM1, IRAK3, CASP3, TNFRSF11B, PTGES, CASP8, FAS, 
CASP1, EPO, SELP, PTGER2, CD40, GJB6, IDO1, LGALS9, 
SOD2, PCK1, TNFRSF9, RPS6KA3, JAK2, F2R 
positive regulation of inflammatory response 0.000 
LPL, CCL2, TNFSF4, S100A8, S100A9, TLR2, TLR3, TLR4, 
CX3CL1, CCL5, TNFSF18, S100A12, CD47, SERPINE1, 
TGM2, PLA2G7, NLRP12, JAK2, XCL1, TNIP1 
I-kappaB kinase/NF-kappaB signaling 0.000 IRAK2, TNF, TBK1, RELB, TLR3, TIFA, TLR4, NFKB1, 
NFKB2, BIRC3, TANK, RIPK3, RBCK1, BCL3, RIPK2, 
IKBKB, CD14, RNF31 
cellular response to lipopolysaccharide 0.000 
CSF3, ICAM1, IL-6, SBNO2, CCL2, TNFSF4, CEBPB, TNF, 
LITAF, NFKBIB, CXCL8, NFKB1, TLR4, CD40, CMPK2, 
CXCL10, EDNRB, CCL20, CD80, CXCL16, SERPINE1, 
ZC3H12A, NOS2, TNFAIP3, CD14 
activation of cysteine-type endopeptidase activity involved in 
apoptotic process 0.000 
XDH, TNF, S100A8, S100A9, PML, EGLN3, TNFSF15, 
SMAD3, SLC11A2, CASP3, TNFSF10, IFI27, ROBO1, IFT57, 
CASP8, NLRP12, NKX3-1, JAK2, FAS, CASP1, F2R 
cellular response to interleukin-1 0.000 
ICAM1, IL-6, CCL2, CEBPB, EDN1, CHI3L1, CXCL8, 
NFKB1, CX3CL1, CCL5, TANK, PCK1, ADAMTS7, CCL22, 
HIF1A, CCL20, ZC3H12A, NKX3-1, XCL1 
JAK-STAT cascade 0.000 STAMBP, IFNAR2, STAT4, NMI, CCL2, SOCS2, STAT5A, SOCS1, IL15RA, JAK2, STAT1, STAT3, STAT2 
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negative regulation of viral genome replication 0.000 RNASEL, TNF, IFITM2, RSAD2, IFI16, PARP10, CCL5, ISG20, ISG15, LTF, EIF2AK2, MX1, TNIP1, ADAR 
positive regulation of I-kappaB kinase/NF-kappaB signaling 0.000 
TNF, LITAF, TBK1, TLR6, TRIM5, NOD2, TRIM8, CASP8, 
TGM2, RBCK1, LTF, CASP1, IL1A, RNF31, CFLAR, 
NDFIP2, TRIM25, MALT1, CD40, BIRC3, LGALS9, 
S100A12, IKBKE, APOL3, TRIM38, TNFSF10, RIPK2, 
IKBKB, F2R 
tumor necrosis factor-mediated signaling pathway 0.000 
PSMB10, TNFRSF21, TNF, TNFSF4, TNFSF15, CD40, 
BIRC3, STAT1, TNFSF18, PSMB8, PSMB9, BAG4, 
TNFRSF9, PSMF1, CARD14, TNFRSF11B, TNFSF13B, 
PSMA6, PSME2, PTK2B, JAK2, FAS, IKBKB, LTB 
cellular response to tumor necrosis factor 0.000 
ZFAND6, ICAM1, TNFRSF21, IL-6, CCL2, EDN1, CHI3L1, 
CXCL8, CX3CL1, CCL5, TANK, PCK1, VCAM1, ADAMTS7, 
BAG4, CYBA, MAP3K5, CCL22, CCL20, NKX3-1, ZC3H12A, 
IKBKB, XCL1 
negative regulation of type I interferon production 0.000 DDX58, IKBKE, CYLD, IFIH1, ISG15, TBK1, HERC5, UBA7, UBE2L6, TRIM25, TNFAIP3, DHX58 
regulation of inflammatory response 0.000 
SBNO2, TNFSF4, LYN, PTGS2, RICTOR, BIRC3, NOD2, 
CASP4, PSMA6, PGLYRP2, MGLL, PIK3AP1, JAK2, XCL1, 
CASP1, TNFAIP3, TNIP1 
positive regulation of GTPase activity 0.000 
FGF18, RASGEF1B, RASGEF1A, ITSN2, GDPGP1, SMAP2, 
S1PR1, RINL, STARD8, ANGPT1, DOCK10, RAPGEF2, 
NET1, ARHGAP9, ICAM1, ARHGEF6, ARHGEF9, CD40, 
ARHGAP26, THY1, ARHGEF11, ARHGAP31, SH2D3A, 
ARFGEF3, GNAQ, ARRB1, NCK1, RIN3, KALRN, FGFR1, 
CCL2, CX3CL1, CCL5, DENND2D, OCRL, FAM13A, 
TAGAP, CCL22, CCL20, ARHGAP42, TEK, CAMK2D, 
CAMK2B, TRIP10, CAMK2A, FGD3, RASA2, ELMOD1, 
IL2RB, NF1, DENND1A, DOCK9, LAT, FNBP1, ADAP2, 
RGS2, RABEP1, RGS3, DENND4C, RGS7, JAK2, XCL1, ST5, 
IL3RA, ARHGAP10 
signal transduction 0.000 FGF18, S100A9, IL19, TNFSF15, TLR2, TLR3, PLPPR3, 
TLR6, TNFSF18, CXCL10, ANK1, UNC5B, STARD8, 
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IL15RA, IL-1B, FAS, MX1, ITPK1, NET1, OPTN, TANK, 
TNFAIP6, HIF1A, ARRB1, CD34, LRP12, RIPK3, RIPK2, 
MST1R, KALRN, TRAF1, SRI, ZNF516, CCL2, LITAF, 
NFKBIB, NOSTRIN, SP110, CD72, OCRL, VDR, TAGAP, 
LGALS3BP, CD69, TEK, NDRG2, MAP2K1, NR4A2, 
NDFIP2, SMAD1, ATF6, LAT, APOL3, TNFSF10, CD274, 
HIVEP2, HIVEP1, XCL1, PLAU, ARHGAP10, NAMPT, 
NFKB1, SDC4, ASAH2, FLT3LG, LNPEP, TNFRSF11B, 
PTGES, CASP1, LTB, ARHGAP9, LYN, NRXN3, NECTIN2, 
ARHGAP26, CD83, ARHGAP31, TNFSF13B, RASSF10, 
ICOSLG, RIN3, TNFRSF21, CXCL5, C3, SAV1, CXCL8, 
FAM13A, CCL22, CCL20, PTK2B, ARHGAP42, CAMK2B, 
TRIP10, PLA2R1, RASA2, EPO, LY75, IL18R1, IL2RB, 
TNFSF4, NF1, COL15A1, ASIC3, MAPK10, TNFSF9, STAT3, 
ITPR2, RASSF4, RPS6KA3, RASSF6, NLRP12, JAK2 
positive regulation of interleukin-6 production 0.000 IL-6, TNF, TNFSF4, ADORA2B, TLR2, TLR3, TLR4, DDX58, CYBA, NOD2, IL-1B, RIPK2, IL1A, IL36A 
response to hypoxia 0.000 
CCL2, TLR2, EGLN3, PML, ADA, SLC11A2, VCAM1, 
HMOX2, CASP3, CXCR4, PTK2B, TEK, CAMK2D, NOS2, 
CASP1, EPO, MT3, MUC1, PLAT, NF1, FUNDC1, NR4A2, 
SMAD3, SOD2, ITPR2, CYBA, HIF1A, NPPC, PLAU 
angiogenesis 0.000 
NRP2, FGF18, FGFR1, CCL2, PTGS2, CXCL8, ANPEP, 
ESM1, EPHB2, WARS, S1PR1, HEY1, UNC5B, PTK2B, 
ITGAV, TEK, SERPINE1, ERAP1, ZC3H12A, ANGPT1, 
ADAM8, C1GALT1, CEACAM1, FMNL3, NRXN3, 
COL15A1, ACKR3, TMPRSS6, THY1, HIF1A, CLIC4, RBPJ, 
TNFAIP2, SEMA4A 
positive regulation of chemokine production 0.000 IL-6, TNF, HIF1A, ADORA2B, TLR2, RIPK2, TLR3, TLR4, EIF2AK2 
positive regulation of ERK1 and ERK2 cascade 0.000 
FGF18, CCL2, TNF, TLR4, CX3CL1, CCL5, CCL22, NOD2, 
CD44, CCL20, PTK2B, TEK, CAMK2D, ANGPT1, RAPGEF2, 
EPO, MT3, ICAM1, C5AR2, IL-6, MAP2K1, CHI3L1, ACKR3, 
LGALS9, ARRB1, RIPK2, XCL1, ST5, F2R 
118 
 
positive regulation of nitric oxide biosynthetic process 0.000 ICAM1, IL-6, TNF, NOS1AP, PTGS2, PTK2B, EDN1, SMAD3, IL-1B, TLR4, JAK2, INSR, SOD2 
lipopolysaccharide-mediated signaling pathway 0.000 IRAK2, TNF, CCL2, LYN, TLR2, RIPK2, NFKBIA, IL-1B, TLR4, CCL5, CD14 
chemotaxis 0.000 
PLD1, C5AR2, CCL2, CXCL5, MAP2K1, C5, CXCL2, 
CXCL8, ACKR3, CX3CL1, ACKR4, CCL5, CCL28, LGALS9, 
CXCL10, CCRL2, CCL22, S1PR1, CCL20, CXCR4, CXCL16, 
PLAU 
positive regulation of NF-kappaB import into nucleus 0.000 IL18R1, TNF, PTGS2, TLR2, RBCK1, TLR3, IL-1B, TLR4, LGALS9 
chemokine-mediated signaling pathway 0.000 
CCL2, CXCL5, CXCL3, CXCL2, CXCL8, ACKR3, ACKR4, 
CX3CL1, CCL5, CXCL10, CCRL2, CCL22, CCL20, CXCR4, 
PTK2B, XCL1 
TRIF-dependent toll-like receptor signaling pathway 0.000 IKBKE, TBK1, IRF7, CASP8, TLR3, TLR4, BIRC3, IKBKB, CD14, TANK 
cytokine-mediated signaling pathway 0.000 
LRRC4, CSF3, IL1R2, IL-6, IL2RB, CCL2, SOCS2, IL-6ST, 
SOCS1, CX3CL1, STAT3, IRAK3, STAT4, IL17REL, IL20RA, 
TGM2, IL-1B, IL15RA, JAK2, IL13RA1, IL1A, IL36A 
acute inflammatory response 0.000 B4GALT1, VCAM1, IL-6, TNFSF4, S100A8, PTGES, VNN1 
positive regulation of nitric-oxide synthase biosynthetic process 0.000 
NAMPT, NOD2, CCL2, CCL20, TLR2, TLR4, JAK2 
response to tumor necrosis factor 0.000 CASP3, PTGS2, NUB1, CXCL16, CASP8, CHI3L1, JAK2, YTHDC2, CD14  
negative regulation of apoptotic process 0.000 
IL-6ST, FOXO1, NFKB1, TNFSF18, SETX, EDNRB, BAG4, 
CASP3, CD44, LTF, ANGPT1, FAS, MT3, SOX10, SOCS2, 
BCL2A1, PIM1, RHBDD1, MAP4K4, CARD14, TNFAIP8, 
RIPK2, AVEN, NAIP, EIF2AK2, ALOX12, ARL6IP1, 
ZFAND6, NFKBIA, SQSTM1, PTK2B, TEK, TGM2, BCL3, 
CFLAR, IL2RB, IL-6, TMBIM4, BIRC7, SMAD3, MALT1, 
119 
 
BIRC3, STAT3, SOD2, PLAC8, IFIT3, RPS6KA3, IKBKB, 
ADAR, ARHGAP10 
positive regulation of interferon-beta production 0.000 DDX58, IFIH1, TBK1, IRF7, TLR2, IRF1, RIPK2, TLR3, TLR4 
regulation of I-kappaB kinase/NF-kappaB signaling 0.000 ZFAND6, TNF, SQSTM1, NLRP12, IL-1B, ANGPT1, OPTN 
regulation of cell proliferation 0.000 
TNFRSF21, TNF, APOBEC1, FGR, CXCL3, TNC, SAV1, 
CXCL2, EGLN3, NFKBIA, CXCL10, TNFRSF11B, PTK2B, 
NOS2, FAS, RAPGEF2, PTGER2, BIRC7, CD40, TYK2, 
PLA2G4A, STYK1, MELTF, TFRC, JAK2, PLAU 
regulation of adaptive immune response 0.000 TNFSF4, IRF7, RIPK3, DUSP10, IRF1 
cellular response to organic cyclic compound 0.000 TNF, CEBPB, CCL2, NFKBIA, STAT1, CCL5, STAT3, CYBA, NOD2, CASP3, P2RY6, CASP8, IL-1B 
response to cytokine 0.000 IFI27, SP100, PTGES, OSMR, IL-6ST, CXCL16, CD274, 
RELB, PML, NFKB2, SKIL, STAT1 
regulation of apoptotic process 0.000 
TNFRSF21, BCAR1, NOD2, TNFRSF11B, CASP4, DYNAP, 
CASP8, BCL3, FAS, SKIL, CASP1, BMP3, CFLAR, BCL2L14, 
BMP1, NOS1AP, STK26, MALT1, WRN, TRIM24, BIRC3, 
STAT1, TNFRSF9, CARD14, RASSF6, IFT57, JAK2, 
EIF2AK2 
regulation of tumor necrosis factor-mediated signaling pathway 0.000 TRAF1, CYLD, TNF, CASP8, RBCK1, BIRC3, IKBKB, TNFAIP3, RNF31 
MAPK cascade 0.000 
PSMB10, FGF18, FGFR1, CCL2, TNF, RASGEF1A, CCL5, 
MAP3K7CL, SETX, PSMF1, MAP3K5, PTK2B, MAP3K1, 
TEK, CAMK2D, IL-1B, ANGPT1, CAMK2B, RAPGEF2, 
CAMK2A, RASA2, IL2RB, MAP2K1, NF1, SMAD1, 
PSMB8, PSMB9, LAT, PSMA6, PSME2, JAK2, IL3RA  
antigen processing and presentation of endogenous peptide antigen 
via MHC class I 0.000 TAP2, TAP1, ERAP1, ERAP2, TAPBP 
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response to amino acid 0.000 ICAM1, SLC1A2, CASP3, IL-6, CCL2, LYN, EDN1, AARS, NAIP 
sodium ion transmembrane transport 0.000 
SLC8A3, SLC5A5, SHROOM2, ASIC3, KCNK1, PKD2L1, 
SLC34A2, SLC17A2, SLC24A1, SLC4A7, NALCN, SLC8B1, 
SCNN1D, TRAPPC10 
positive regulation of interferon-alpha production 0.000 DDX58, IFIH1, TBK1, IRF7, RIPK2, TLR4 
positive regulation of phosphatidylinositol 3-kinase signaling 0.001 CSF3, SELP, FGFR1, FGR, CCL5, PRR5, UNC5B, TEK, NKX3-1, PIK3AP1, ANGPT1, JAK2, F2R 
cell chemotaxis 0.001 CCL2, CXCL5, BCAR1, C5, CXCL2, SAA4, CX3CL1, CCL5, CCL28, CXCL10, VCAM1, CCL20, SAA2  
cellular response to interferon-gamma 0.001 CIITA, CCL22, CCL2, GBP5, CCL20, EDN1, TLR3, CX3CL1, NOS2, CCL5, XCL1, LGALS9  
neutrophil chemotaxis 0.001 CCL2, S100A8, CXCL3, S100A9, EDN1, CXCL8, CX3CL1, CCL5, S100A12, CCL22, CCL20, IL-1B, XCL1  
positive regulation of sequence-specific DNA binding transcription 
factor activity 0.001 
IL-6, TNF, SP100, SAV1, FOXA1, EDN1, TRIM14, TRIM25, 
PLPP3, TRIM21, DDX58, TRIM5, TRIM38, TRIM8, TRIM34, 
IL-1B, JAK2 
JNK cascade 0.001 IRAK2, MAP3K5, NOD2, TNF, SH2D3A, ADORA2B, ARHGEF6, NPHS1, DUSP10, RIPK2, MAPK10 
negative regulation of extrinsic apoptotic signaling pathway via death 
domain receptors 0.001 
ICAM1, CFLAR, TNFSF10, CASP8, SERPINE1, TMBIM1, 
RFFL, FAS, TNFAIP3  
regulation of innate immune response 0.001 FGR, IRF1, SAMHD1, ERAP1, BIRC3, DHX58 
positive regulation of interleukin-8 production 0.001 DDX58, NOD2, TNF, SERPINE1, TLR2, TLR3, IL-1B, TLR4  
ion transport 0.001 
SLC8A3, SLC9A8, SLC5A5, SLCO4A1, TMC5, SLC22A15, 
SLC9A2, ATP11B, SLCO2B1, SLC26A2, LRRC38, 
SLC26A4, SLC1A2, SLC24A1, SLC5A8, LTF, SLC8B1, 
SLC15A3, SLC1A1  
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positive regulation of transcription from RNA polymerase II 
promoter 0.001 
NAMPT, RNASEL, ELF3, TBK1, EDN1, TLR2, FOXO1, 
TLR3, NFKB1, TLR4, ZEB1, NFKB2, CXCL10, FLT3LG, 
SETX, PCGF5, NOD2, S1PR1, SPX, HEY1, SERPINE1, IL-
1B, TNIP1, IL1A, CIITA, SOX10, SSBP3, SSBP2, TAF4B, 
RELB, NCOA7, SIX5, CD40, IFI16, ELL3, AHR, NRIP1, 
ADRB2, HIF1A, NCOA2, ARRB1, NCK1, RIPK2, CSF3, 
SBNO2, TNF, PML, NFKBIA, EHF, LIF, VDR, STAT4, 
SQSTM1, POU2F2, BCL3, AGO2, ZC3H12A, NKX3-1, 
BCL9L, ETV6, SLC30A9, MAFF, IL-6, CEBPB, IKZF2, 
ZBTB7C, CEBPD, FOXA1, NR4A2, SMAD3, SMAD1, 
STAT1, TMPRSS6, STAT3, PLAC8, DDX58, ATF6, 
RPS6KA3, MEOX1, IRF7, AIRE, IRF1, ID4, EAF2, RBPJ, 
IKBKB  
pattern recognition receptor signaling pathway 0.001 TRIM5, PGLYRP4, PGLYRP2, PGLYRP3, CLEC7A 
positive regulation of cell migration 0.001 
FGR, LYN, DIAPH1, BCAR1, CSF1, FERMT3, EDN1, 
SMAD3, CCL5, TNFAIP6, S1PR1, PTK2B, ITGAV, 
CARMIL1, RRAS2, CXCL16, CD274, SEMA4B, JAK2, INSR, 
PLAU, SEMA4A, F2R, ALOX12 
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KEGG analysis pathways that were up-regulated in epithelial cells treated with 100 ng/mL LGALS1  
Legionellosis 0.000 
IL-6, TNF, C3, CXCL3, CXCL2, TLR2, CXCL8, NFKBIA, 
TLR4, NFKB1, NFKB2, CASP3, CASP7, CASP8, IL-1B, 
NAIP, CASP1, CD14 
Chagas disease (American trypanosomiasis) 0.000 
ADCY1, TNF, GNAI3, CCL2, GNAI1, C3, TLR2, CXCL8, 
NFKBIA, TLR4, NFKB1, TLR6, CCL5, SERPINE1, CASP8, 
IL-1B, PIK3R5, NOS2, FAS, CFLAR, IL-6, SMAD3, MAPK10, 
GNAQ, IKBKB 
Chemokine signaling pathway 0.000 
ADCY1, CCL2, GNAI3, FGR, CXCL5, GNAI1, NFKBIB, 
CXCL3, BCAR1, CXCL2, CXCL8, NFKBIA, NFKB1, 
CX3CL1, CCL5, CCL28, CXCL10, CCL22, CCL20, CXCR4, 
PTK2B, PIK3R5, MAP2K1, LYN, NCF1, STAT1, STAT3, 
STAT2, GNGT2, ARRB1, CXCL16, JAK2, XCL1, IKBKB 
Rheumatoid arthritis 0.000 
ICAM1, IL-6, TNF, CCL2, CXCL5, CSF1, TLR2, CXCL8, 
TLR4, ATP6V1B2, CCL5, MMP1, ATP6V1C2, TNFSF13B, 
CCL20, CD80, TEK, IL-1B, ANGPT1, LTB, IL1A 
Cytosolic DNA-sensing pathway 0.000 
IL-6, TBK1, NFKBIB, NFKBIA, TREX1, NFKB1, CCL5, 
CXCL10, DDX58, IKBKE, IRF7, RIPK3, IL-1B, IKBKB, 
CASP1, ADAR, ZBP1 
Tuberculosis 0.000 
TNF, RAB5B, C3, TLR2, NFKB1, TLR4, TLR6, VDR, 
CASP3, NOD2, CLEC4E, CASP8, CAMK2D, IL-1B, 
CAMK2B, NOS2, PLA2R1, CAMK2A, IL1A, CIITA, 
IRAK2, IL-6, CEBPB, RFX5, MALT1, MAPK10, STAT1, 
RIPK2, JAK2, CLEC7A, CD14 
Toxoplasmosis 0.000 
CIITA, TNF, GNAI3, GNAI1, NFKBIB, SOCS1, BIRC7, 
TLR2, NFKBIA, NFKB1, TLR4, MAPK10, CD40, BIRC3, 
STAT1, STAT3, TYK2, CASP3, LAMA4, CASP8, JAK2, 
NOS2, IKBKB 
Hepatitis B 0.000 IFIH1, TNF, TBK1, STAT5A, TLR2, CXCL8, TLR3, NFKBIA, 
TLR4, NFKB1, STAT4, CASP3, PTK2B, MAP3K1, CASP8, 
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PIK3R5, FAS, IL-6, MAP2K1, MAPK10, STAT1, STAT3, 
STAT2, DDX58, IKBKE, IRF7, IKBKB 
HIF-1 signaling pathway 0.000 
IL-6, MAP2K1, EDN1, EGLN3, HK2, HK1, NFKB1, TLR4, 
STAT3, HIF1A, TFRC, TEK, SERPINE1, CAMK2D, ANGPT1, 
PIK3R5, CAMK2B, NOS2, CAMK2A, INSR, EPO 
Osteoclast differentiation 0.000 
TNF, NCF2, MAP2K1, NCF1, CSF1, SOCS1, RELB, NFKBIA, 
NFKB1, NFKB2, MAPK10, STAT1, STAT2, TYK2, IRF9, 
IFNAR2, CYLD, CYBA, TNFRSF11B, SQSTM1, IL-1B, 
PIK3R5, IKBKB, IL1A, BLNK 
Leishmaniasis 0.000 
TNF, PTGS2, NCF2, MARCKSL1, C3, NCF1, NFKBIB, TLR2, 
NFKBIA, NFKB1, TLR4, STAT1, CYBA, IL-1B, JAK2, NOS2, 
IL1A 
Jak-STAT signaling pathway 0.000 
CSF3, OSMR, IL-6ST, STAT5A, IL19, IL21R, LIF, STAT4, 
IL15RA, PIK3R5, IL13RA1, EPO, IL-6, IL2RB, SOCS2, 
SOCS1, PIM1, STAT1, STAT3, STAT2, IRF9, TYK2, IFNAR2, 
IL20RA, JAK2, IL3RA 
Inflammatory bowel disease (IBD) 0.000 
IL18R1, IL-6, TNF, IL18RAP, IL21R, TLR2, SMAD3, 
NFKB1, TLR4, STAT1, STAT3, NOD2, STAT4, IL-1B, 
IL1A 
Hepatitis C 0.001 
RNASEL, TNF, TBK1, CXCL8, NFKBIA, TLR3, NFKB1, 
OAS2, MAPK10, STAT1, STAT3, STAT2, DDX58, IRF9, 
TYK2, IKBKE, IFNAR2, IRF7, IRF1, PIK3R5, EIF2AK2, 
IKBKB 
Malaria 0.001 
VCAM1, CSF3, ICAM1, SELP, IL-6, TNF, CCL2, TLR2, 
CXCL8, IL-1B, TLR4, CD40 
Epstein-Barr virus infection 0.001 
ICAM1, LYN, TBK1, NFKBIE, NFKBIB, RELB, NFKBIA, 
NFKB1, NFKB2, CD40, MAPK10, STAT3, DDX58, TYK2, 
CD44, PIK3R5, EIF2AK2, RBPJ, IKBKB, TNFAIP3 
Hematopoietic cell lineage 0.001 
CSF3, IL1R2, IL-6, TNF, CSF1, ANPEP, FLT3LG, DNTT, 
TFRC, CD44, CD34, IL-1B, CD14, IL1A, IL3RA, EPO 
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Adipocytokine signaling pathway 0.001 
TNF, NFKBIE, NFKBIB, NFKBIA, NFKB1, MAPK10, 
STAT3, PCK1, JAK2, ACSL4, IKBKB, ACSL3, ACSL6, 
ACSL5 
Apoptosis 0.001 
CFLAR, CASP3, TNFSF10, TNF, CASP7, CASP8, NFKBIA, 
NFKB1, PIK3R5, FAS, BIRC3, IKBKB, IL3RA 
Type II diabetes mellitus 0.002 
TNF, SOCS2, GCK, SOCS1, HK2, HK1, CACNA1E, 
PIK3R5, MAPK10, IKBKB, INSR 
African trypanosomiasis 0.002 
VCAM1, ICAM1, LAMA4, IL-6, TNF, GNAQ, IL-1B, 
IDO1, FAS 
Amoebiasis 0.004 
IL1R2, ADCY1, IL-6, TNF, RAB5B, TLR2, CXCL8, TLR4, 
NFKB1, LAMA4, CASP3, GNAQ, SERPINB1, IL-1B, PIK3R5, 
NOS2, CD14 
Pathways in cancer 0.004 
TRAF1, FGF18, FGFR1, ADCY1, GNAI3, PTGS2, GNAI1, 
STAT5A, EGLN3, PML, CXCL8, NFKBIA, LPAR3, FOXO1, 
NFKB1, NFKB2, MMP1, FLT3LG, EDNRB, CASP3, CXCR4, 
ITGAV, CASP8, NKX3-1, PIK3R5, FAS, NOS2, IL-6, 
PTGER2, MAP2K1, BIRC7, SMAD3, MAPK10, BIRC3, 
STAT1, STAT3, ARHGEF11, CBLC, LAMA4, GNGT2, 
HIF1A, GNAQ, IKBKB, F2R 
Inflammatory mediator regulation of TRP channels 0.005 
ADCY1, PTGER2, ASIC3, MAPK10, ITPR3, ITPR2, 
PLA2G4A, GNAQ, P2RY2, CAMK2D, IL-1B, PIK3R5, 
CAMK2B, CAMK2A, ALOX12, PLA2G4D 
Sphingolipid signaling pathway 0.006 
PLD1, TNF, PPP2R3A, GNAI3, MAP2K1, GNAI1, SGPP2, 
NFKB1, CERS4, MAPK10, ASAH2, S1PR3, MAP3K5, 
S1PR1, GNAQ, ABCC1, PIK3R5, PPP2R3C 
Phagosome 0.006 
STX7, OLR1, RAB5B, NCF2, NCF1, C3, TLR2, TLR4, 
C1R, ATP6V1B2, TLR6, ATP6V1C2, CYBA, TFRC, 
ITGAV, TAP2, TAP1, CLEC7A, PLA2R1, CD14, TUBA1C 
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